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Recurrent HSV-1 ocular disease results from reactivation of latent virus in trigeminal 
ganglia (TG), often following immunosuppression or exposure to a variety of psychological or 
physical stressors. HSV-specific CD8+ T cells can block HSV-1 reactivation from latency in ex 
vivo TG cultures in part through production of IFN-γ. Here we establish that either CD8+ T cell 
depletion or exposure to restraint stress permits HSV-1 to transiently escape from latency in 
vivo. Restraint stress caused a glucocorticoid-associated reduction of TG-resident HSV-specific 
CD8+ T cells, and a functional compromise of those cells that survive, at least partly mediated by 
catecholamines. Together, these effects of stress resulted in an approximate 65% reduction of 
cells capable of producing IFN-γ, and impairment in the ability of those cells to release lytic 
granules, in response to reactivating virus. We also establish that restraint stress during the 
primary infection results in a 54% reduction of virus-specific IL-7Rα+ memory precursor cells in 
the TG at the peak of expansion. When mice stressed early were stressed again during latency, 
their T cell response may be further compromised. Our findings demonstrate persistent in vivo 
regulation of latent HSV-1 by CD8+ T cells, and strongly support the concept that stress induces 
HSV-1 reactivation from latency at least in part by compromising CD8+ T cell surveillance of 
latently infected neurons.   
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PREFACE 
“Whence Reason o’er the world presides, 
And man from brute, and man from man, divides; 
Compares and measures by imagined lines 
Ellipses, circles, tangents, angles, sines; 
Repeats with nice libration, and decrees 
In what each differs, and in what agrees; 
With quick volitions unfatigued selects 
Means for some end, and causes of effects; 
All human science worth the name imparts, 
And builds on Nature’s base the works of arts.” 
 
Erasmus Darwin, from The Temple of Nature 
published posthumously in 1803 
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1.0  INTRODUCTION 
1.1 STATEMENT OF THE PROBLEM 
Control of latent herpesvirus infections is a multifaceted process that involves the virus, the 
infected cell, and the host immune system. Upon ocular herpes simplex virus type 1 infection, 
the virus establishes a latent state in the trigeminal ganglia, where it remains for the life of the 
host. Viral latency is controlled in part by surveillance by activated memory T cells of the host 
immune system. Various stimuli result in the reactivation of the latent virus, leading to recurrent 
disease at the site of primary infection and potentially to more severe consequences. 
Psychological stress is a well-known inhibitor of the T cell response to herpes simplex virus and 
has been associated with reactivation of latent virus. We hypothesized that psychological stress 
could induce viral reactivation by compromising the efficacy of ganglion-resident CD8+ 
memory T cells.  We tested this hypothesis using a mouse model of herpes simplex virus type 1 
corneal infection and latency and restraint, a well-established model of psychological stress. 
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1.2 HERPES SIMPLEX VIRUS TYPE 1 
1.2.1 Epidemiology and Disease 
Herpes simplex virus type 1 (HSV-1, also known as human herpesvirus 1 [HHV-1]) is a 
ubiquitous human pathogen that infects a majority of people worldwide. In the US, 
seroprevalence of HSV-1 increases from 44% in young adults (aged 12-19 years) to 90% in 
persons aged >70 years, and overall HSV-1 seroprevalence is 68% (1). These trends are similar 
to those observed in populations worldwide, although HSV-1 prevalence may actually vary 
widely by country, region within a country, population subgroup, socioeconomic status, and risk 
behavior (1,2).  
Primary HSV-1 infection is often asymptomatic but may manifest as a cold sore or fever 
blister on the mouth or lip. Most HSV-1 infections occur early in life via close contact with 
infectious mucosal secretions (3). The virus can infect the sensory nerves that innervate the site 
of primary infection, travel up the axon to the neuron cell body, and establish latency, a lifelong 
association of nonreplicative viral genomes within neurons. Host and viral genetic determinants 
and the initial inoculum size influence the amount of latent viral genomes that are retained, as 
well as the ability of the virus to reactivate from latency, the process by which latent genomes 
are replicated and produce infectious progeny (4-7). Up to 5% of the normal adult population 
asymptomatically sheds HSV-1 at any given time (3). Clinical HSV-1 disease can lead to a 
spectrum of consequences including herpes labialis, gingivostomatitis, herpetic stromal keratitis, 
endophthalmitis, and potentially lethal encephalitis. Pregnant woman can transmit virus to their 
child in utero, intrapartum, or postnatally. These infections can prove fatal to the fetus or 
newborn (3).  
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HSV-1 is genetically very similar to HSV-2, a sexually transmissible pathogen that often 
leads to genital lesions. HSV-1 can also infect the genital area and establish latency in dorsal root 
ganglia. However, genital HSV-1 infections are usually less severe clinically and reactivate less 
frequently than HSV-2 (3). These phenomena may be attributable in part to a difference in the 
neuron subtype in which HSV-1 and HSV-2 preferentially establish latency (8).  
There are a wide variety of strategies for designing vaccines against HSV-1 and HSV-2, 
both prophylactic and therapeutic. One major hindrance to vaccine development is the inability 
of circulating antibody to effectively limit recrudescent disease. At the present time, there are no 
vaccines that prevent either HSV infection or reactivation from latency (3,9). Therefore, HSV 
disease management is mainly limited to the use of antiviral drugs such as acyclovir. As these 
drugs target viral DNA synthesis, they are only effective during productive infection and neither 
prevent the virus from establishing latency and may not prevent latent virus from reactivating 
(3,10,11).  
1.2.1.1 Herpes Stromal Keratitis 
In the US, HSK is the leading cause of infectious disease-related blindness and a leading 
indication for corneal transplantation (11). In humans, HSK is an immunopathology that results 
from periodic reactivation and recurrent viral antigen presentation in the cornea. Conversely, 
most animal models of HSK derive from primary disease (12). The immune infiltrate in the 
cornea that follows ocular HSV-1 infection produces inflammatory cytokines, such as IFN-γ and 
IL-2, which, although protective against skin disease, are immunopathologic in the cornea (13-
15). Despite the requirement for viral replication in the induction of HSK in mice (16), HSK in 
humans does not usually respond to anti-herpetic drugs and is treated clinically with 
corticosteroids, to reduce inflammation (17,18). For the studies presented in this dissertation, we 
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used the C57BL/6 mouse strain to model HSV-1 infection and latency: the abundance of 
immunologic reagents available, existence of a defined immunodominant H-2Kb-restricted viral 
epitope, and the development of HSK make this mouse model an excellent choice (19,20).  
 
1.2.2 Morphology and Genome Structure 
HSV-1 is a linear double-stranded DNA (dsDNA) virus and the prototypical member of the 
alphaherpesvirus sub-family of the family Herpesviridae. The HSV-1 virion (Figure 1) is 
approximately 200 nm wide and is comprised of four basic units: (i) a core containing the 
approximately 152 kbps dsDNA viral genome, (ii) an icosadeltahedral capsid comprised of viral 
proteins, (iii) a tegument layer containing viral proteins necessary for efficient initiation of viral 
transcription, and (iv) a lipid bilayer envelope derived from the host membrane with viral 
glycoproteins embedded within (21).  
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 Figure 1. The HSV-1 virion. 
Viral double-stranded DNA (dsDNA) is contained within the capsid. The capsid is 
surrounded by a tegument layer and an outer envelope from which various viral 
glycoprotein spikes extend. Figure not to scale.  
 
The HSV-1 genome is segmented into two unique DNA segments, called the unique long 
(UL) and unique short (US) regions, flanked by inverted repeats (Figure 2). The repeats of the UL 
segment are designated ab and b’a’, and the US segment repeats are designated a’c’ and ca. The 
genome contains approximately 84 open reading frames located on both DNA segments; some 
genes are present in two copies and located in the repeat regions. The genome size is not 
absolute, however, and may contain multiple copies of inverted repeats of variable size (21). The 
UL and US segments can be found inverted relative to one another, and within a population of 
HSV-1, the viral genomes are present in equimolar concentrations of four isomers, designated P 
(prototype), IL (inversion of UL), IS (inversion of US), and ISL (inversion of UL and US). All four 
isomers give rise to infectious virus (21).  
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 Figure 2. Illustration of the HSV-1 genome.  
The genome is divided into unique long (UL) and unique short (US) portions partitioned 
by inverted repeat sequences at the termini (a, b, c) and internally (a’, b’, c’). Figure not 
to scale.  
1.2.3 Life Cycle 
The HSV-1 life cycle is divided into three basic categories: (i) productive, or lytic, infection, 
which results in the production of infectious progeny virus and lysis of the host cell; (ii) non-
productive, or latent, infection, in which viral gene transcription is limited and no infectious 
progeny are produced; and (iii) reactivation from latency, the process by which viral gene 
transcription during latency leads to DNA replication and de novo production of infectious 
progeny virus in the absence of any tegument or virion components. Figure 3 shows a simplified 
illustration of lytic and latent infections.  
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 Figure 3. Lytic and latent infections. 
(A) In a lytic infection, virus enters the cell via interactions with cell surface receptors 
(see text) and virus DNA is transcribed and translated in a tightly regulated, temporal 
manner. Viral DNA is synthesized, packaged into newly formed virions, and exported out 
of the cell. (B) In a latent infection, the virus enters the target neuron where the DNA is 
contained in a histone-bound extrachromasomal episome. During latency there is limited 
viral gene expression, but a major gene product produced is the stable mRNA LAT (see 
text). Figure not to scale.   
1.2.3.1 Lytic Infection 
Lytic infection is initiated upon infection of a susceptible target cell. Infection begins as 
viral glycoproteins on the surface of the HSV-1 envelope bind to target cell surface receptors. 
Glycoprotein B (gB), gC, gD, gE, gG, gH, gI, gJ, gK, gL, and gM have all been shown to be 
expressed on the HSV-1 surface, but not all are critical for virus attachment and entry.  
Attachment of HSV-1 to its target cell is mediated by binding of gC or gB to 
glycosaminoglycan moieties, such as heparan sulfate, on the cell surface. Entry of HSV-1 to its 
target requires binding of gD to one of several receptors on the cell surface, including the 
herpesvirus entry mediator (HVEM, or HveA), a member of the tumor necrosis factor (TNF) 
receptor superfamily; nectin-1 and nectin-2, members of the immunoglobulin (Ig) superfamily; 
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and 3-O-sulfated heparan sulfate. Virus entry into the target cell is complete upon fusion of the 
viral envelope to the target cell plasma membrane, a process that requires gB, gD, and the gH/gL 
complex. Following viral fusion, the nucleocapsid is transported to the nucleus with some of the 
tegument proteins. Other tegument proteins remain in the cytoplasm, such as virus host shutoff 
(vhs), a protein that immediately begins to degrade host mRNA. When the nucleocapsid reaches 
the nuclear pore, the viral DNA is released into the nucleus. There the viral tegument VP16 
associates with host cell factor (HCF) and Oct-1, a transcription factor that binds to the 
TAATGARAT sequence in viral immediately early (IE, or α) promoters.  
HSV-1 gene transcription is organized in a tightly regulated, sequential manner (Table 1). 
The α genes are the first to be transcribed; their transcription does not require de novo viral 
protein synthesis. IE genes encode proteins that are important for turning on the transcription of 
the other two classes of genes: early (E, or β) genes, which are important for viral DNA 
synthesis, and late (L, or γ) genes, which are important for capsid assembly and include the 
glycoproteins. The γ genes are split into two subclasses, γ1, which can be transcribed prior to 
DNA replication but peak after DNA synthesis, and γ2, which require DNA replication for their 
transcription.  
Table 1. Classes of HSV-1 genes. 
Class Kinetics of transcription Functions 
Immediate Early (α) Prior to de novo protein synthesis 
Transactivate β and γ gene transcription; 
repress host and α gene transcription; 
immune evasion 
Early (β) 
After de novo protein 
synthesis, prior to DNA 
replication 
DNA replication machinery  
Leaky-Late (γ1) 
Initiated prior to DNA 
replication, majority 
transcribed after 
Virus attachment and assembly; tegument 
proteins 
True-Late (γ2) Requires DNA replication for transcription 
Capsid assembly; virus attachment; 
tegument proteins 
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IE (α) genes are transcribed as early as 2 to 4 h post infection (p.i.). There are six α 
genes, infected cell protein 0 (ICP0), ICP4, ICP22, ICP27, ICP47, and US1.5, a protein encoded 
in a region overlapping with ICP22. Although all α genes except ICP47 can stimulate gene 
expression, the two most important α proteins are ICP0 and ICP4. ICP0, an E3 ubiquitin ligase, 
is a promiscuous transactivator of transcription, but does not itself bind DNA. ICP0 is not 
essential for viral replication, yet it is important for optimal infection, gene expression, and 
reactivation from latency (21-23). ICP0 may also be important in the fate decision between lytic 
and latent infections, although its role is still contentious (24-27). Additionally, ICP0 has a role 
in repressing interferon (IFN)-stimulated genes, a collection of genes that are central to the host 
defense against HSV-1 infection (28-31). The other major α gene is ICP4, a potent transactivator 
of transcription for β and γ genes, and a repressor of α gene expression (21). ICP4 can bind DNA 
at both consensus and nonconsensus sites. Indeed, most β and γ promoter regions do not contain 
putative ICP4 binding domains. ICP4 also binds host transcription factors and modulates their 
activity as a method for indirectly activating viral genes (32-34). It should be noted that the 
promoter regions for α, β, and γ genes are structurally quite different. As depicted in Figure 4, α 
promoters contain a TAATGARAT element and binding sites for various transcription factors, 
often including a putative ICP4 binding site. β promoters contain upstream binding sites for 
transcription factors, but do not have a consensus ICP4 binding sequence. γ promoters contain 
minimal upstream transcription factor binding sites, but do have an initiator element (Inr) and 
often contain downstream activation sites (21,35).  
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 Figure 4. Schematic illustration of HSV-1 gene promoters. 
General structure of α, β, and γ promoters is shown. The number and arrangement of cis-
acting regulatory elements varies among promoters of each class. (A) α promoters 
contain a TATA box and upstream TAATGARAT elements, as well as binding sites for 
transcription factors (i.e. Sp1) and, in some α promoters, ICP4, which may repress gene 
transcription. (B) In addition to a TATA box, β promoters contain upstream binding sites 
for transcription factors, here denoted as Sp1 and a CAAT box. (C) γ promoters contain a 
TATA box, and an initiator element (INR). Some γ promoters also contain a downstream 
activation site. Adapted from (35). Figure not to scale.  
 
The β genes reach peak rates of expression between 4 and 8 h p.i. This gene class 
contains the viral DNA replication machinery, including the origin binding protein, single-
stranded DNA binding protein, the DNA helicase-primase complex, the DNA polymerase, and 
various protein kinases. HSV-1 DNA has traditionally been thought to replicate first by theta 
replication, and then later, by rolling circle replication (21,36), although recent data has called 
this process into question (24). Rolling circle replication results in the production of viral DNA 
concatemers that are then cleaved as the DNA is packaged into new virions.  
Generally, the late (γ) genes do not reach peak gene expression until after DNA synthesis. 
The leaky-late (γ1) genes are expressed in low amounts early in infection, but increase several-
fold after DNA replication has occurred. The true-late (γ2) genes are absolutely dependent on 
viral DNA synthesis for their expression; these differences may be due in part to variations in the 
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structures of their promoters. γ genes include the capsid assembly proteins, the glycoproteins 
important for virus attachment and entry into target cells, antiapoptotic proteins, and various 
tegument proteins, including VP16, the activator of α gene expression upon infection (21,35).  
1.2.3.2 Latent Infection 
A hallmark of herpesvirus infections is latency, a quiescent state in which viral gene 
expression is limited, replication of viral DNA does not occur, and viral progeny are not 
synthesized. HSV-1 establishes latency in the peripheral neurons that innervate the site of 
primary infection. In our corneal infection model, latency is established in the trigeminal 
ganglion (TG), the sensory ganglion that innervates the eye, nose, and mouth. Here the viral 
DNA exists as an extra-chromosomal episome tightly associated with histones (37). The 
mechanism by which the virus enters latency is not fully characterized, but may involve 
circularization induced by ICP0 downregulation (24). As opposed to the well-characterized 
regulation of viral genes observed during lytic infection (Section 1.2.3.1), in latency there is 
minimum expression of viral genes, and viral proteins are difficult to detect (38). One gene 
product that is abundantly expressed during latency is the latency associated transcript (LAT), a 
lariat-shaped intronic RNA species, in part antisense to ICP0, that may act in neurons to help 
prevent apoptosis (39,40). LAT may also be important for both the entry into, and escape from, 
neurons, but is not required for establishment of latency (41-43). A newly discovered micro 
RNA species encoded by the LAT gene (miR-LAT) has been shown to prevent apoptosis in cell 
culture, and may work in vivo by enhancing survival of latently infected neurons by inhibiting 
transforming growth factor (TGF)-β signaling (44). It should also be noted that the sensory 
neurons within the TG are a heterogeneous population, phenotypically defined by at least two 
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populations based on expression of the A5 and KH10 surface markers (4). Both neuron subtypes 
are infected proportionally in acute infection, but latency is preferentially established by HSV-1 
in the A5 neuronal population and by HSV-2 in the KH10 neuronal population (8). This 
difference could be reversed using recombinant viruses that expressed the opposite LAT 
molecules (8,45). Thus, expression of LAT, and, perhaps, miR-LAT expression, may promote 
survival of latently infected neurons by inhibiting either virus-induced, or immune-mediated, 
apoptosis.   
1.2.3.3 Reactivation from Latency 
The exact point where latency ends and reactivation begins is still rather contentious. 
HSV-1 latency is classically defined as the retention of a functional viral genome in the extended 
absence of infectious virus particles (46). Clinically, this definition makes sense since recurrent 
disease can only occur in the presence of infectious virus. Therefore, having reactivation begin at 
virion formation allows for the transient or extended expression of a limited array of viral lytic 
genes during latency in the absence of DNA replication, as is seen with other herpesviruses. 
Figure 5 shows a simplified cartoon overview of the establishment of, and reactivation from, 
latency in our corneal infection model. 
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 Figure 5. Latency and reactivation. 
A cartoon depiction of the two main phases of the virus life cycle in the trigeminal 
ganglion in our model. (A) Establishment of latency: virus infects the cornea where it 
gains access to sensory nerve termini. Virus then travels up the axon by retrograde 
transport to the trigeminal ganglia, where it has restricted gene expression and does not 
produce infectious virions (see text). (B) Reactivation:  one of any number of stimuli 
initiate viral DNA replication in the TG, leading to production of infectious virus 
particles which travel down the axon by anterograde transport back to the site of initial 
infection, leading to recurrent disease (see text). Figure not to scale. CNS, central nervous 
system.  
 
Exactly what viral genes are required for reactivation from latency is currently unknown. 
Limited gene expression has been observed in the absence of virion formation, including the γ2 
gene gC (38,47,48). However, recombinant viruses lacking proteins such as ICP4, ICP8 and TK 
are capable of establishing latency (evidenced by LAT expression), but fail to reactivate (21,49). 
In cell culture, recombinant viruses missing all or some α genes establish quiescent infections, 
but do not replicate (50), but addition of ICP0 to quiescently infected fibroblasts or latently 
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infected neurons in culture can induce reactivation (51,52). Spontaneous HSV-1 reactivation is 
extremely rare in the mouse (38,53),  but cellular stresses such as hyperthermia, UV irradiation, 
and TG explant can all induce reactivation of latent virus (54,55). Of these, UV irradiation and 
hyperthermia have been shown to induce ICP0 promoter activity (56). In some models, 
reactivation is accompanied by changes in cytokines, chemokines, or upregulation of the 
intracellular cyclin-dependent kinase (cdk)-2 and cdk-4 (57,58). 
Recent work in our lab and others has begun to delineate a role for the immune system in 
actively maintaining latency by preventing viral reactivation (reviewed in (46,59), and discussed 
below). Reactivation can be inhibited by the antiviral cytokines gamma-interferon (IFN-γ) and 
tumor necrosis factor (TNF)-α (52,60), both of which are expressed in latently infected ganglia 
(61,62). Hyperthermia-induced reactivation is increased in IFN-γ receptor knockout mice versus 
controls, suggesting IFN-γ plays a protective role in vivo (63).  Indeed, addition of IFN-γ to TG 
cultures can prevent reactivation by inhibiting ICP0 promoter activity as well as events 
downstream of the gC promoter (52).  CD8+ T cells, which are present in latently infected 
ganglia, can prevent reactivation ex vivo (64-66), and have been shown to produce IFN-γ and 
TNF-α in response to antigenic stimulation (65,67). Thus, a combination of host immune, neuron 
intrinsic and viral factors may be required for full induction of reactivation of latent HSV-1.  
1.3 IMMUNITY TO HSV-1 
The pathogenesis of HSV-1 is tempered by the actions of the host immune system. There are two 
main mechanisms of mammalian immunity: the innate and adaptive immune responses. The 
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innate immune response is not restricted by pathogen specificity, but instead relies on pattern 
recognition receptors to distinguish self from non-self. Adaptive immunity, on the other hand, is 
generated toward specific defined antigens and results in the formation of a memory response 
that allows for a quicker, more robust secondary response in the event of re-infection or 
reactivation of a latent infection. An innate immune response does not culminate in memory 
generation; each subsequent response is neither stronger nor weaker than the previous response.  
1.3.1 Innate immune response to HSV-1 
In our ocular infection model, HSV-1 first infects corneal epithelial cells at the site of 
inoculation. In response, these cells produce type I IFN antiviral cytokines, such as IFN-α and 
IFN-β. The presence of IFN-α induces the migration of macrophages and polymorphonuclear 
(PMN) cells such as neutrophils into the central cornea. This primary immune infiltrate, 
consisting of macrophages, neutrophils, natural killer (NK) cells, and γδ TCR+ cells (68-71), is 
most important in initial clearance of HSV-1 from the cornea. Despite the innate immunity in the 
cornea, virus undoubtedly gains access to sensory nerve termini and reaches the TG. Although 
unique intrinsic properties of neurons may contribute to the control of HSV-1 replication in the 
TG, the host innate and adaptive immune systems provide a second level of protection. Indeed, 
the initial control of HSV-1 replication within the TG clearly involves components of innate 
immunity.  HSV-1 begins to replicate in the TG within 2-3 days of corneal infection (72), 
although the majority of genomes enter latency immediately upon accessing the TG  
Concurrently, the TG is infiltrated by macrophages and γδ TCR+ T cells (73,74).  The 
macrophages produce antiviral molecules such as nitric oxide (NO) and TNF-α (75).  Depleting 
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macrophages, blocking NO production, or neutralizing TNF-α during the first 5 days after HSV-
1 corneal infection significantly increases viral titers and the number of infected neurons in the 
TG (75). These findings suggest that macrophages function within the TG to limit virus 
replication and lateral spread.  
Depletion of γδ TCR+ T cells from mice during the first 7 days after corneal infection 
also increased virus replication and spread and eliminated most of the early type II interferon 
(IFN-γ) production within the TG (75,76).  IFN-γ not only possesses antiviral activity, but is also 
a potent activator of macrophages, inducing their production of NO and TNF-α (77).  Thus, early 
control of HSV-1 replication and spread in the TG appears to involve an orchestrated response in 
which γδ TCR+ T cells activate macrophages to produce antiviral compounds. Type I IFN also 
appear important in the early control of HSV-1 replication in the TG; they are produced after 
corneal infection concurrent with virus transport to the ganglion (78). In addition, over-
expression of IFN-α1 in astrocytes inhibited HSV-1 replication and establishment of a latent 
infection in the TG (78). Another study showed that in primary TG cultures transduced with an 
adenoviral vector expressing IFN-β, HSV-1 replication was repressed in a dose–dependent 
fashion (79). Together, these findings demonstrate that innate immunity is primarily responsible 
for controlling early HSV-1 replication in the TG following primary infection, which is not 
surprising in light of the fact that the bulk of viral replication occurs during the first 5 days after 
infection, a time when the adaptive immune response is developing in the lymphoid organs.   
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1.3.2 Adaptive Immunity to HSV-1 
In addition to the innate immune response, the body defends itself by the adaptive immune 
response, a system that can respond to specific pathogens and develops memory, the ability to 
respond faster and more vigorously upon reinfection. The main players in the adaptive immune 
response are professional antigen presenting cells, antibody-producing B cells, and T 
lymphocytes. T cells come in many flavors with many functions, but the three main classes of T 
lymphocytes are CD4+FoxP3+ T regulatory cells (Treg), CD4+ T helper cells (Th), and CD8+ 
cytotoxic T lymphocytes (CTL). For simplicity and relevance, the bulk of background 
information presented here will focus on the T cell response, particularly CD8+ T cells.  
T cells originate in the bone marrow from hematopoietic stem cells and, in the thymus, 
undergo several linear phases that differentiate pluripotent progenitors into either CD4+ or CD8+ 
T cells. These two coreceptors are instrumental in the recognition of host major 
histocompatibility complexes (MHC) by T cells. In the thymus, T cells undergo gene 
rearrangements that result in the expression of cell surface T cell receptors (TCR). The T cells 
are then selected first by positive selection, in which cells expressing TCR that do not recognize 
MHC molecules expressed by cells in the thymus are eliminated, and then by negative selection, 
in which cells that react to MHC molecules and ubiquitous self ligands are eliminated. These 
processes ensure that the cells that migrate out of the thymus are specific for non-self antigens 
that can be presented by specific MHC types. The coreceptors CD8 and CD4 are important for 
reaction to MHC class I and MHC class II, respectively, although in the absence of CD4+ T cells 
and in other cases, MHC class II-restricted CD8+ T cells may develop (80-82). Once T cells have 
left the thymus, they migrate to lymph nodes (LN) and other regions of lymph tissue such as the 
Peyer’s patches and spleen. There, these naïve, antigen-inexperienced cells wait for the proper 
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antigen stimulation to proliferate and form a memory response. It has been estimated that the 
frequency of naïve T cells specific for any given antigen specificity is remarkably low (83-86).  
The T cell response to acute pathogens in vivo can be divided into four main phases, i) 
activation and expansion, ii) contraction, iii) long-lived memory,and iv) vigorous recall (87). 
Before a T cell response can be initiated, however, professional antigen presenting cells (APC) 
such as Langerhans cells or dendritic cells (DC) must pick up antigen at the initial site of 
infection. MHC class I-restricted peptides are generated by the immune proteasome, and are 
generally 8-10 amino acids long. The DC that is expressing the antigen travels to the draining 
lymph node (LN) and there presents the antigen itself or potentially passes the antigen off to non-
migratory, LN-resident APC (88).  
T cell priming in the LN requires three distinct signals that combine to regulate the 
potency of the primary T cell-mediated immune response as well as secondary responses. The 
first signal is cognate MHC and antigen complexes presented by professional APC. The second 
signal is costimulation. Mature, activated DC express costimulatory ligands on their cell surface 
that react with receptors on the surface of the responding T cell. For CD8+ T cell stimulation, 
important costimulatory DC-expressed molecules appear to be B7.1 and B7.2, which bind to 
CD28 on the T cell (89,90), and may be most important early in priming (91), and 4-1BBL, 
which binds to 4-1BB (92,93), and may be more important later in the primary response and for 
secondary responses (91). These molecules, among others, help ensure that the CD8+ T cell 
responds by expansion and development of memory instead of a state of functional anergy, or 
tolerance (94). The third signal is inflammation, which can be provided by IL-12, type I IFN, or 
signals from toll-like receptor (TLR) ligands.  In some models, IL-12 promotes proliferation or 
cell survival during the primary response or plays a role in the development of cytotoxicity (95-
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98). Type I IFN can also promote activated T cell survival and differentiation into effector cells 
(99-101). The effects of these stimuli may overlap and vary greatly depending on the model of 
antigen stimulation or infection (102,103). Interestingly, IL-12 signals have recently been shown 
to influence the expression of the transcription factor T-bet, which may be important in the 
commitment decision between becoming a short-lived effector cell or a long-lived memory cell 
(104,105). 
It is not certain exactly what length of interaction is required for APC to present antigen 
to a T cell to initiate expansion, the window of presentation has been experimentally measured to 
be within the first 3 d of infection (106,107) and antigen presentation in the LN has been 
observed in as little as 2 h following HSV-1 infection in a transgenic mouse model, even though 
expansion of the activated cells did not begin until 24 h post infection (108,109). The term 
expansion refers to the proliferation of cells (up to 50,000-fold over naïve numbers) following 
activation and the migration out of the lymph nodes and into the periphery (110,111). Migration 
out of the lymph nodes is mediated by various chemokines and their receptor expression on the 
newly activated CD8+ T cells, as well as downregulation of adhesion molecules such as CD62 
ligand (CD62L) on the T cells. In ocular HSV-1 infections, DC in the cornea take up HSV 
antigens and migrate out of the eye to draining LN, where the antigens are presented to naïve T 
cells with proper costimulation. During expansion, T cells migrate out of the LN to the cornea 
(the site of initial inflammation), the TG (the site of viral latency), and numerous other tissues 
and organs, where, following contraction (a dramatic loss of effector cells), persistent memory 
pools remain for the life of the host (65,67,68,112-115). These results are in accordance with 
other studies showing promiscuous localization of CD8+ memory T cell responses (116-118). 
Virus-specific effector CD8+ T cells at sites of infection with a variety of viruses have been 
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shown to express the receptors CCR2, CCR5, and CXCR3, matching the typical chemotactic 
cytokine (chemokine) profile of RANTES, MIP-1α and β, IP-10, and MCP-1 (119).  RANTES 
and MIP-1 bind to CCR5, IP-10 binds to CXCR3, and MCP-1 binds to CCR2 (120).  IP-10 and 
RANTES have been demonstrated to be in the TG of mice latently infected with HSV-1 
(62,121). These chemokines are not only important for the migration of effector cells to target 
tissues, but also for maintaining T cell numbers at peripheral sites.  
 Since latency is uniformly established by 10 d in our corneal infection model, and 
contraction leaves a stable memory population in the TG and elsewhere to monitor the latent 
virus, the factors that regulate the generation and maintenance of the memory pool are of 
considerable importance.  
It is not yet known exactly when in an immune response memory precursors are 
programmed to become memory cells. Expression of the IL-7Rα subunit (CD127) during the 
effector phase has been shown to be correlated with generation of T cell memory, and IL-7Rα+ 
effector T cells have come to be known as memory precursor cells (122). These memory 
precursor cells somehow survive the contraction phase and develop into long-lasting memory 
cells, which, following an acute infection, may not require TCR-mediated signals for their 
continued survival (123,124). However, expression of IL-7Rα is not sufficient for survival 
following acute viral infections or peptide-pulsed DC immunizations (125-127), and IL-7 signals 
are not required for the generation of a memory pool (128,129). The surface molecule killer cell 
lectin-like receptor G1 (KLRG1) has recently been associated with development of short-lived 
effector cells (104,125). KLRG1 expression appears to influence cell senescence, and 
upregulation of KLRG1 may signal a commitment to a shortened lifespan (104,130) and reduced 
functionality (131). Additionally, expression of the transcription factors T-bet and eomesodermin 
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may influence the lineage decision of newly activated T cells (105,132). Inflammation may play 
a role in the generation of memory cells, as IL-12 has recently been reported to regulate 
expression of T-bet and eomesodermin (104,133,134).  
Recently, Chang, et al. have shown that when a CD8+ T cell is primed by an APC 
expressing its cognate peptide/MHC complex and proper costimulatory molecules, the T cell 
divides in an asymmetric manner, sequestering certain proteins (CD3, CD8, LFA-1) to the 
proximal pole and other proteins (PKC-ζ) to the distal pole. In a TCR transgenic system, distal 
daughter cells protect better than proximal daughters following bacterial infection 30 d after 
transfer into a naïve host (135). These data suggest that T cell lineage commitment may occur as 
early as the first division during priming.  
It is intriguing that the fate of a T cell could be determined as early as priming, but 
environmental factors certainly play a role in the establishment and survival of the memory pool. 
Inflammation and antigen load, in particular, appear to mediate the rate and extent of the 
contraction phase, and the rate at which memory cells develop (127,136-138). Chemokine 
expression may also influence memory cell generation. A recent report identified downregulation 
of the chemokines CCL19, CCL21, and CXCL13 in the spleen during acute infections, and 
during immunizations with virus-like particles (139). The transient downregulation occurred 
even while chemokines such as MCP-1 and RANTES were increased, and it was dependent on 
the presence of CD4+ T cells and expression of IFN-γ (139). The downregulation may also 
influence the expression of sphingosine-1-phosphate (S1P)-1, a lipid molecule that is required 
for lymphocyte egress from lymphoid organs (140). Type I IFN induce CD69 upregulation and 
binding to S1P1, mediating S1P1 downregulation, and retaining the activated cells within 
lymphoid tissues (141).  
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Mature CD8+ T cells appear to exist in at least four stages of differentiation: naïve, 
effector, effector memory, and central memory. These stages have been defined phenotypically 
based on differential expression of various receptors and molecules, outlined in Table 2. Naïve 
cells become effectors upon priming, and the majority of effector cells are eliminated during the 
contraction phase, leaving populations of the effector memory and central memory phenotypes.  
Table 2. Phenotype of mature CD8+ T cells. 
 CD62L CD18 CD44 CD69 Ly6C CCR7 
Naïve hi low low - low hi 
Effector low hi hi + hi low 
Effector Memory low hi hi +/- hi low 
Central Memory hi hi hi - hi hi 
 
In systemic acute infection models, the majority of memory cells are of the central 
memory phenotype, and their numbers are proportional to the initial burst size during expansion 
(142). Persistent or latent infections, however, result in memory cells that persist as effector 
memory cells (143). CD8+ effector memory T cells are functionally distinct from central memory 
cells, and the size of the effector memory CD8+ T cell pool is less dependent on the initial burst 
size (144). Perhaps the most striking difference between effector and central memory cells are 
their localization within the immune host. While central memory cells reside mainly in lymphoid 
organs, effector memory cells reside primarily in non-lymphoid tissues, and may form the first 
line of defense against reinfection (144). Functionally, CD8+ effector memory T cells are 
heterogeneous. In some systems they appear very similar to effector cells in that they produce 
IFN-γ and are cytotoxic directly ex vivo. These cells are functionally distinct from central 
memory cells that produce little IFN-γ, lack granzyme B expression, and are not cytotoxic, but 
they maintain perforin expression. In other systems, CD8+ effector memory cells produced large 
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amounts of IFN-γ but lacked lytic function (143).  The reason for these differences has not been 
determined. A recent study by Woodland and colleagues investigated memory function closely 
and determined that it was the activation phenotype of the memory cell (i.e., CD27, CD43, and 
CXCR3 expression) that determined the functional hierarchy of memory, as opposed to the 
localization phenotype (i.e., CD62L and CCR7 expression) that has been traditionally used to 
distinguish memory populations (145). In their analysis of CD44+CD8+ T cells, they defined 
populations, CXCR3hiCD27hiCD43lo cells were the best, CXCR3hiCD27hiCD43hi cells were 
intermediate, and CXCR3loCD27loCD43lo cells were the poorest responders, and each population 
contained cells of both effector memory and central memory phenotypes (145). These data 
confirm a previous study examining activation status and function of memory cells to chronic 
infections in humans (146).  
In our model, virus-specific CD8+ T cells enter the TG beginning at 6 d p.i., and their 
numbers peak around 8 d p.i. (65). Whether there is a secondary expansion within the TG is 
currently under investigation. Expansion in the LN is followed by a severe contraction of CD8+ 
T cell number. How much of contraction is due to programmed cell death and how much is due 
to migration out of the LN is unknown. The contraction phase is observed throughout the mouse, 
however, and in the TG, there is approximately a 80-90% reduction in CD8+ T cell number by 34 
d p.i. compared to the peak at 8 d p.i. (65). A sizable population of CD8+ T cells remains in the 
host for the life of the animal (65,68). This retention of CD8+ T cells is also observed in humans, 
where latently infected neurons remain surrounded by CD8+ T cells throughout life (114,115). In 
humans and mice, the population of virus-specific T cells that reside in the TG throughout 
latency are in an activated state (65,115), whereas virus-specific memory CD8+ T cells in non-
infected organs are not activated (67). The ganglion-resident CD8+ memory T cell pool is best 
 23 
defined as activated effector memory cells, as they express high levels of CD44, CD69 and IL-
7Rα, produce IFN-γ and TNF-α upon ex vivo stimulation, are cytotoxic directly ex vivo, and are 
positive for granzyme B and perforin (65,67,147,148). Initial migration into the TG appears to 
require extensive cell division and upregulation of the activated isoform of CD43, but CD43 is 
soon downregulated at peripheral sites (149).  
The factors that govern the maintenance of a memory population are still under intense 
investigation. Exposure to antigen may be required for maintenance of effector memory 
populations (which often reside in tissues infected with viruses that cause persistent or latent 
infections) (150), whereas central memory populations may be maintained through homeostatic 
proliferation (123,151-153). In acute infections, CD8+ T cell memory forms following the 
elimination of the pathogen, and is maintained by homeostatic proliferation regulated by the 
cytokines IL-2, IL-7, and transpresentation of IL-15 (154-160). Chronic infections, on the other 
hand, appear to generate an “exhausted” CD8+ T cell memory population that is incapable of 
responding to homeostatic signals from these cytokines (161-164). Maintenance of this 
population requires constant antigenic exposure, resulting in reduced expression of the IL-7 and 
IL-15 receptors, and upregulation of inhibitory receptors such as programmed death 1 (PD-1).  
The resulting memory population is functionally impaired, lacking cytotoxic function and 
incapable of producing IFN-γ and TNF-α (165-168). Function can be transiently restored by 
systemic treatment with antibody to the PD-1 ligands PD-L1, expressed promiscuously in 
tissues, and PD-L2, expressed only on APC (165,169-171).  Recently, interaction of PD-L1 with 
B7-1 on T cells was shown to repress T cell activation and cytokine production (172).  
Latent HSV-1 infections represent a situation where CD8+ T cells are intermittently 
exposed to low levels of antigen exclusively in the sensory ganglia. This compartmentalized 
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persistent expression of viral antigens allows for comparison of the requirements for maintaining 
CD8+ memory T cell populations in infected and non-infected tissues of the same animal (67). 
Here, neither IL-15 nor IL-2 are required for the maintenance of CD8+ memory T cell numbers 
in the TG, presumably due to persistent low level antigen stimulation. In contrast, the HSV-
specific memory population decays over time in the absence of IL-15 in the lungs, where there is 
no latent virus or viral antigen expression. IL-15 deficiency was also associated with a functional 
compromise in IFN-γ synthesis and degranulation, but not TNF-α production (67), suggesting 
that even though the numbers of memory cells remained constant in the TG, their ability to 
monitor latently infected neurons may have been impaired. The results of this study confirm a 
previous report in which IL-15 administration protected mice from a lethal systemic HSV-2 
infection (173). Another rather intriguing property of the TG is the potential for regulation of the 
CD8+ memory T cell response by the neurons themselves. TG neurons have been shown to 
express the nonclassical MHC-Ib molecule Qa-1b, which binds to the NK cell receptor G2A 
family (NKG2A) inhibitory receptor and CD94 heterodimer complex expressed on CD8+ T cells 
in the TG (148,174). Blocking this interaction results in cytolysis of neurons ex vivo (148), 
which presumably does not normally occur, as CD8+ T cells have been shown to be able to 
prevent reactivation in an IFN-γ-dependent, non-cytolytic mechanism (52,60,64). MHC-I 
expression is also required for the maintenance of the HSV-specific CD8+ memory T cell pool. 
Although specific antigen presentation by cells within the ganglion is not required for the 
infiltration of virus-specific cells, expression of granzyme B decreases in virus-specific CD8+ 
memory T cells when the immunodominant H-2Kb-restricted gB498-505 epitope cannot be 
presented in the ganglion by parenchymal cells (147). Thus, it appears that antigen presentation 
by MHC-I molecules within the ganglion during latent HSV-1 infection is instrumental for 
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maintenance of a proper memory T cell response, at least in part by overriding the requirement 
for IL-15 (67,147). Whether the MHC signals are provided by the latently infected neurons 
themselves is still unknown, but neurons have been shown to upregulate MHC-I during acute 
HSV-1 infection (175) and IFN-γ can induce MHC-I expression in neurons (176), leaving the 
possibility open that latently infected neurons can positively regulate the CD8+ memory pool via 
presentation of MHC-I. Indeed, a recent study demonstated that virus-mediated downregulation 
of MHC-I increased reactivation from latency (177).  Additonally, gB498-505-specific CD8+ T 
cells in latently infected ganglia polarize their TCR toward select neurons, suggesting the 
establishment of an immunologic synapse between the T cell and the neuron (65), and thus, 
another indication of neuronal MHC-I expression during latency. 
Virus-specific CD8+ T cells can prevent HSV-1 reactivation from latency in ex vivo TG 
cultures in an MHC-restricted manner (64,65,145,177). This protection is mediated at least in 
part by CD8+ T cell synthesis and secretion of IFN-γ, a potent antiviral cytokine that can directly 
inhibit HSV-1 gene expression and prevent reactivation in ex vivo TG cultures (52,60,65).  
Taken together, the above information all points to a complex system that involves 
antigen duration, inflammatory cytokines, chemokines, and CD4+ T cell help that program, and 
then guide, a naïve cell to a memory cell fate. Once established, however, CD8+ T cell memory 
populations face many additional mechanisms by which their numbers and functionality can be 
altered. 
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1.4 THE STRESS RESPONSE 
The stress response is a simple term used to describe a complex and integrated series of events 
that connects the nervous, immune, and endocrine systems. In humans, ultraviolet (UV) 
radiation, psychological and physical stress, and immune compromise have all been shown to 
induce HSV-1 reactivation from latency. In animal models, stress, UV radiation, hyperthermia, 
hypothermia, shaking, and immunosuppression by dexamethasone treatment are all associated 
with inducing reactivation from latency. The ability of many of these stimuli to enhance 
reactivation may stem from the activation of the stress response. Stress has long been associated 
with HSV-1 reactivation, but currently stress has not been definitively shown to cause 
reactivation through any direct mechanism (178).   
Figure 6 shows a cartoon depiction of the two main functional arms of the stress 
response: the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system 
(SNS).  
 27 
 Figure 6. The stress response. 
Blue dashed lines represent negative regulatory pathways, solid red lines represent 
positive regulatory pathways. Green dashed lines represent bimodal regulatory pathways. 
Black lines represent action of inhibitors. CRH, corticotropin releasing hormone; ACTH, 
adrenocorticotropin hormone; SNS, sympathetic nervous system; 6-OHDA, 6-
hydroxydopamine; RU486, mifepristone. Adapted from (179,180).  
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1.4.1 The Hypothalamic-Pituitary-Adrenal Axis 
The HPA axis is a series of signaling events that originate in the paraventricular nucleus of the 
hypothalamus upon physical, psychosocial, or inflammatory stimulation. Three important 
molecules of the human HPA axis are corticotropin releasing hormone (expressed in the 
hypothalamus), adrenocorticotropin-releasing hormone (released into the bloodstream by the 
anterior pituitary gland), and cortisol (synthesized and released from the adrenal glands) 
(180,181). These molecules act in a sequential manner resulting in the production and release of 
cortisol, the main glucocorticoid effector molecule of the human stress response. In mice, the 
adrenal steroid corticosterone serves this role. Glucocorticoids can then signal back to the 
hypothalamus and pituitary to downregulate the HPA axis (Figure 6 and (179)).  
Adrenal steroids function through both type I (mineralcorticoid) and type II 
(glucocorticoid) receptors. Both receptor subtypes are expressed in immune cells, albeit at 
different levels in different tissues. Although type I receptors have a much higher binding 
efficiency for glucocorticoids, it is expression of type II receptors that determines the 
susceptibility of a cell to glucocorticoids. The type II receptors bind glucocorticoids, become 
activated through a conformational change, localize to the nucleus, dimerize, and then bind DNA 
(182). Corticosteroid binding globulin (CBG) binds free corticosteroids thus preventing an 
interaction with glucocorticoid receptors. An increase in corticosteroid production down-
regulates CBG production, establishing a positive feedback loop of corticosteroid action. 
In reference to a latent HSV infection, the effects of stress hormones and glucocorticoids, 
in particular, are not well understood. Changes in T cell localization or proliferation due to 
glucocorticoids may be sufficient to allow HSV to reactivate from latency. In addition to these 
effects, however, glucocorticoids may also directly act upon the latently-infected neurons, 
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establishing an environment within the cell favorable for HSV reactivation from latency. The 
effects of glucocorticoids in the brain may lead to either enhancement of memory, as is the case 
with acute stress, or damage of the hippocampus, cognition impairment, and general 
neurodegeneration, as with chronic stress (183,184). Glucocorticoids may also cause dendritic 
atrophy, but low levels can protect against neuronal apoptosis during development. On a 
molecular level, glucocorticoids may influence gene expression within latently-infected neurons, 
providing an environment favorable for HSV reactivation. Activated glucocorticoid receptor 
(GR) binding to CREB binding protein (CBP) may enhance an endogenous histone acetylation 
activity of CBP (182). This could allow for previously inaccessible DNA sequences of the latent 
viral episome to become accessible to transcription factors. Although this effect of 
glucocorticoids has not been conclusively shown to occur in neurons, a similar effect in neurons 
might be expected. Glucocorticoids may also repress gene expression by binding to, and 
interfering with, transcription factors such as AP-1, NF-κB, Sp1, Ets, NF-AT, and STATs, some 
of which are involved in transcription of HSV-1 genes (182,185). Glucocorticoids may also act 
by blocking downstream targets of these transcription factors.  
There are many actions of glucocorticoids on immune function. It is generally accepted 
that glucocorticoids can reduce inflammation and, in many models, prevent lethality, in response 
to infection and other inflammatory stimuli. Conversely, blockade of the HPA axis has proven to 
increase mortality and inflammation in these same models (180). It is important to note that acute 
stress (generally less than an hour in animal models) may enhance the immune response whereas 
chronic stress (hours to days) often leads to immune suppression (181,186). Indeed, acute stress 
at the time of vaccination may even act as an adjuvant, inducing a better immune response (187). 
 30 
Currently, however, the mechanism by which duration of stress exposure leads to this dichotomy 
is unknown.  
Corticosterone in mice and rats has been shown to induce lymphoid cell migration out of 
peripheral blood and into tissues. Reduction of lymphocyte numbers from the blood is a common 
readout of stress. Neutrophils react oppositely, however, and neutrophil numbers in the blood are 
increased due to glucocorticoid treatment. These shifts in immune cell distribution are probably 
due to glucocorticoid-induced changes in adhesion molecule expression, either on immune cells 
or epithelial cells, or both. However, change in adhesion molecule expression may not be 
directly due to the glucocorticoid action, but as a consequence of an indirect effect of 
glucocorticoid downregulation of cytokine expression. Glucocorticoids have been shown to 
affect the expression of cytokines such as IFN-α, -β, and -γ, IL-1, IL-2, IL-4, IL-6, IL-8, and 
TNF-α (181,188). Cytokine receptor expression may also be regulated, as IL-2 receptor β and γc 
chains are inhibited, but IL-1 receptor and IL-6 receptor expression are enhanced by 
glucocorticoids (189,190). Interestingly, glucocorticoids induce a shift in immune responses 
from Th1 (IL-2, IFN-γ) to Th2 (IL-4, IL-6). Glucocorticoids also regulate T cell function by 
inducing apoptosis. Although this property of glucocorticoids has been conclusively shown 
during T cell development, many questions remain as to whether they can induce apoptosis in 
peripheral T cells (181). Glucocorticoids are also known to inhibit T cell proliferation and may 
regulate T cell function in part by blocking the cell cycle at G0/G1 (191). Additionally, 
glucocorticoids can inhibit antigen processing by impairing the generation of peptides, leading to 
reduced function of APC (192). 
 31 
1.4.2 The Sympathetic Nervous System 
The main effector molecules of the SNS are catecholamines, including the tyrosine-
derived compounds epinephrine and norepinephrine (193). Catecholamines function via α- or β-
adrenergic receptors on cells. SNS nerve fibers innervate the thymus, spleen, bone marrow, and 
lymph nodes (194-196). Upon SNS activation, norepinephrine (NE) can be released by 
sympathetic neurons, diffuse to surrounding areas, and affect immune cells.  Lymphocyte 
responsiveness to NE depends on β-adrenergic receptor expression, which can be either 
positively or negatively regulated by activation (196). β-adrenergic stimulation leads to increase 
in intracellular cyclic AMP (cAMP).  T cell proliferation has been shown to be impaired by β-
adrenergic receptor signaling and other inducers of cAMP (197-199). In NK cells, specific lysis 
of target cells is compromised by catecholamines at certain concentrations, and the effect is 
reversible by a β-adrenergic receptor antagonist (200). Similar observations, including the 
inhibition of lytic activity, have been made in regard to T cells (201-203).  
It is important to note that NE has been detected in lymphocytes, both by de novo 
synthesis and uptake from extracellular sources. This storage of NE could be an additional 
source of the catecholamine released during stress (204). Catecholamines have also been shown 
to be crucial for the establishment of optimal T cell responses to primary HSV-1 infection, 
suggesting their roles in regulating the immune system are varied (205,206).  
The mechanisms by which catecholamines affect the HSV-specific immune response 
have been studied in some detail. When mice were restrained during a primary footpad infection, 
treatment with the β-adrenergic receptor antagonist nadolol restored cytotoxic ability of cells in 
the draining LN. Blocking Type II corticosteroid (glucocorticoid) receptors with RU486 did not 
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restore cytotoxic ability, suggesting that the stress-induced compromise in cytotoxicity is 
mediated by catecholamines and not glucocorticoids (203). It should be noted that in the same 
study, the stress-induced reduction in draining LN cell number was restored by RU486 treatment 
but not nadolol treatment. These data present a dichotomy of mechanisms induced by restraint 
stress.  
The effects of catecholamines can also be measured by treatment of mice with 6-
hydroxypodamine (6-OHDA), a neurotoxin that selectively destroys the termini of sympathetic 
noradrenergic fibers, but does not cross the blood-brain barrier (207). One caveat of 6-OHDA 
treatment, however, is its activation of HPA axis, resulting in an increase of serum 
glucocorticoid levels (205). Another caveat is that sympathetic denervation by 6-OHDA results 
in a bolus of norepinephrine being released, that may elevate serum and tissue levels of 
norepinephrine (207). In any case, 6-OHDA treatment 1 d p.i. or during latency results in a 
downmodulation of specific lysis of HSV-infected targets. When mice treated with 6-OHDA 
during latency were also treated with nadolol, cytotoxic function was restored (206).  
In addition to affecting virus-specific T cells, catecholamines could potentially directly 
influence viral reactivation by binding to adrenergic receptors on the neuronal cell surface and 
stimulating cAMP production via G-protein coupled receptors (196). The cAMP could then act 
through cAMP response element (CRE) binding protein (CREB) to bind CREs on the latent viral 
episome, initiating transcription of viral genes (208). Whether catecholamines can induce HSV-1 
reactivation by this mechanism is currently unknown.  
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1.4.3 Restraint Stress Model 
Our studies employ a restraint model of psychological stress in which mice are placed in a 50 ml 
conical tube for 12 h, on four consecutive nights (see Section 3.9.3). Several restraint paradigms 
have been shown to upregulate serum levels of corticosterone, the hallmark of stressful stimuli 
(209-213). Additonally, the susceptibility to viral and bacterial diseases is increased following 
the restraint treatment, suggesting that stress, in the form of restraint, can impair immune 
responses (211,214,215), perhaps in part by a delay in the kinetics of humoral and adaptive 
immune responses (216,217). Restraint stress appears to affect both the HPA axis and the SNS, 
as blocking treatments with RU486 or nadolol appear to have differential effects (203).  
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2.0  SPECIFIC AIMS 
The specific goals that were set forth in my thesis proposal and the progress made during my 
studies are summarized below.   
 
Specific Aim I: Define whether and how stress dysregulates CD8+ and CD4+ T cells within 
the TG of C57BL/6 mice latently infected with HSV-1.   
Psychological and physical stressors, and direct application of stress-associated 
hormones, have been shown to impair immune function. We hypothesized that psychological 
stress could induce an observable compromise of T cell efficacy within the latently infected TG. 
To address this aim, we subjected latently infected mice to repeated sessions of restraint and 
observed a CD8+ T cell intrinsic deficiency in IFN-γ in TG culture and at low, physiological 
antigenic epitope densities. Portions of this aim were published in the Journal of Immunology 
(218).  
 
Specific Aim II: Determine if disruption of immune function by stress leads to HSV-1 
reactivation in latently infected neurons.  
Following HSV-1 infection, an activated immune infiltrate enters the TG and remains for 
the life of the animal. We hypothesized that disrupting the function of these activated T cells 
would result in reactivation of HSV-1 from latency. To address this aim, CD8+ T cells were 
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depleted in vivo or mice were restrained or treated with corticosterone to impair T cell function. 
In each case, we measured a significant increase in viral genome copy per TG, and we were able 
to detect viral proteins by immunohistochemistry in stressed TG, indicating that compromising 
CD8+ T cell function in vivo results in reactivation of latent HSV-1. Portions of this aim were 
published in the Journal of Immunology (218).  
 
Specific Aim III: Examine how stress affects the establishment, maintenance, and 
responsiveness of CD8+ memory T cells in the TG of mice latently infected with HSV-1.  
Studies have shown that stress early in viral infection delays the immune infiltrate and 
changes the nature of the primary immune response (209,216,217,219-225). We hypothesized 
that stress during the establishment of the HSV-1 specific memory response influenced not only 
the progression of disease but also the nature of immunological memory upon establishment of 
latency. To address this aim, we corticosterone-treated or stressed mice during acute infection 
and measured CD8+ T cell number, viral genome copy number, and ability to synthesize IFN-γ 
34 d p.i.  
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3.0  MATERIALS AND METHODS 
3.1 MICE AND HSV-1 INFECTION 
Six- to 8-wk-old male C57BL/6J (B6; H-2Kb, CD45.2) or B6.SJL-PtprcaPepcb/BoyJ (B6.SJL; 
H-2Kb, CD45.1) mice (The Jackson Laboratory, Bar Harbor, ME) were anesthetized by i.p. 
injection of 66.7 mg/kg ketamine hydrochloride and 1.33 mg/kg xylazine (Phoenix Scientific, St. 
Joseph, MO) in 0.2 ml HBSS (BioWhittaker, Walkersville, MD). Corneas of anesthetized mice 
were scarified 15-30 times in a crisscross fashion using a sterile 30-gauge needle and eyes were 
topically infected with 3 µl RPMI (BioWhittaker) containing 105 PFU purified wild-type or 
recombinant RE strain HSV-1. Infection efficiency was monitored by topical application of 
fluorescein (Akorn, Abita Springs, LA) 2 days post infection (p.i.) and observed under a slit-
lamp microscope. All animal studies experiments were conducted according to the guidelines of 
the Institutional Animal Care and Use Committee of the University of Pittsburgh.  
3.2 VIRUSES 
Wild-type and recombinant HSV-1 RE strain were grown in Vero cells and intact virions were 
purified using OptiPrep™ gradient columns (Accurate Chemical and Scientific Corporation, 
Westbury, NY) according to the manufacturer’s instructions. Plaque forming units (PFU) of 
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HSV-1 was determined by standard virus plaque assay on Vero cells. Recominant reporter HSV-
1 RE (pgB-EGFP [EGFP driven by the gB promoter], pgC-EGFP [EGFP driven by the gC 
promoter], and pgB-EGFP-pgC-mRed [EGFP driven by the gB promoter and mRed driven by 
the gC promoter]) were produced in collaboration with Dr. Paul R. Kinchington, University of 
Pittsburgh, and their construction is described in detail elsewhere (52,226). 
3.3 REAGENTS 
HSV-1 glycoprotein B (gB) peptide SSIEFARL (gB498-505) was purchased from Research 
Genetics (Invitrogen, Carlsbad, CA). Peptide purity was determined to be greater than 95% by 
reverse phase high performance liquid chromatography analysis. Phycoerythrin (PE)-conjugated 
H-2Kb/gB498-505 tetramers were provided by the NIAID Tetramer Core Facility (Emory Vaccine 
Center, Atlanta, GA). PE-conjugated H-2Kb:Ig dimers (BD Pharmingen, San Diego, CA) were 
complexed to gB498-505 according to manufacturer’s protocol.  
3.4 SINGLE-CELL SUSPENSIONS 
3.4.1 TG 
At various times after infection, mice were euthanized by exsanguination. TG were excised, 
pooled, digested with 100 µl of DMEM (BioWhittaker) containing 10% FCS (HyClone, Logan, 
UT or Atlanta Biologicals, Lawrenceville, GA) and 400 U/ml collagenase type I (Sigma-Aldrich, 
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St. Louis, MO) per TG for 1 h at 37ºC, and dissociated into a single-cell suspension by 
trituration.  
3.4.1.1 Preparation of TG cultures 
TG were dispersed into a single cell suspension as above. TG were washed and resuspended in 2 
ml/TG DMEM with 10% FCS, 50 µM 2-mercaptoethanol (2-ME; Fisher Scientific, Fair Lawn, 
NJ), and 500 U/ml rIL-2 (R & D Systems, Minneapolis, MN). TG cells were dispersed at the rate 
of 200 µl/well (equivalent to 0.1 TG/culture) in a 96-well flat bottom plate (Falcon; Becton, 
Dickinson and Company, Franklin Lakes, NJ) or 400 µl/well (equivalent to 0.2 TG/culture) in a 
48-well plate (Falcon). Cultures were incubated up to 10 d at 37ºC/5% CO2.  
3.4.1.2 Measuring ex vivo cytokine response 
66- or 90-h after culture initiation, 1 µl per TG of Golgiplug™ (BD Pharmingen) was added, 
with or without gB498-505 at 10-12 M (1 µl of the 2 mg/ml working stock per ml culture), and, in 
some cases, with fluorescently-labeled anti-CD107a (BD Pharmingen) or isotype control. 6 h 
later, TG cultures were harvested with versene (8 g NaCl, 0.2 g KCl, 1.15 g dibasic Na2HPO4, 
0.2 g monobasic KH2PO4, 0.2 g Na4EDTA; pH 7.5 in 1 L dH2O), washed, and stained for surface 
markers and intracellular cytokines as described below.  
3.4.1.3 Measuring reactivation of latent virus 
Direct fluorescence microscopy 
TG cultures were examined daily for HSV-1 reactivation by monitoring reporter virus-
infected cultures for spread of fluorescence to the surrounding fibroblast monolayer (52) by 
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imaging on an Olympus BX60 upright microscope with digital camera attachment. Confocal 
imaging was performed on a Nikon TS100F inverted microscope or with an Olympus IX70 
microscope with a Bio-Rad laser-scanning confocal microscope attachment, using 
LaserSharp2000 software (Bio-Rad, Hercules, CA). 
Plaque Assay 
Every other day of TG culture, 30 µl (for 0.1 TG/well cultures) or 60 µl (for 0.2 TG/well 
cultures) of culture supernatant were removed from each well, replaced with fresh culture media, 
and stored at -80ºC. Samples were then thawed and plated on monolayers of Vero cells for 1 h at 
37ºC. Samples were then overlayed with media containing 0.5% methylcellulose for 48 h. 
Detection of virus from latent TG cultures indicates HSV-1 reactivation.  
Ab-mediated depletion of cells from culture 
TG suspension were depleted of either CD8+ (Ly-2) or CD45+ cells by positive selection 
using antibody-conjugated DynaBeads (Dynal Biotech, Invitrogen) per manufacturer’s 
instructions. In short, TG were incubated with beads at a 6:1 bead to cell of interest ratio for 2 
min, 4-7 times, at room temperature on a magnet (Advanced Magnetics, Cambridge, MA) then 
washed between incubations with buffer (PBS/2% FCS). Flowthrough was collected and 
resuspended in TG culture media for plating. Depletion efficiency was determined by flow 
cytometry or hemacytometer count. 
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3.4.2 Spleens 
Splenocytes were collected by grinding spleens through a 40 µm cell strainer and rinsing with 
media. Preparations were washed, incubated 5 min at room temperature in red blood cell lysis 
buffer (0.16 M NH4Cl, 0.17 M Tris, in dH2O, pH 7.2), and then washed again. A 20 µl aliquot 
was then diluted in 10 ml azide-free isotonic diluent (Val Tech Diagnostics, Breckenridge, PA) 
and counted on a Coulter Z2 Particle Count and Size Analyzer (Beckman Coulter, Fullerton, 
CA).  
3.5 FLOW CYTOMETRY 
3.5.1 Determination of surface phenotype 
Purified or fluorochrome-conjugated Abs against CD4 (clone: RM4-5), CD8α (53-6.7), CD8β.2 
(53-5.8), CD16/CD32 (2.4G2), CD25 (7D4 or PC61), CD44 (IM7), CD45 (30-F11), CD45.1 
(A20), CD69 (H1.2F3), CD107a (1D4B), NKG2A/C/E (20d5), IFN-γ (XMG1.2), TNF-α (MP6-
XT22),  and 5-bromo-2-deoxyuridine (BrdU, 3D4), were purchased from BD Pharmingen. 
Fluorochrome-conjugated Abs against CTLA-4 (UC10-4B9), FoxP3 (FJK-16s), and NKG2D 
(CX5) were purchased from eBioscience (San Diego, CA); allophycocyanin (APC)-conjugated 
anti-granzyme B Ab (GB11) was purchased from Caltag (Carlsbad, CA). When appropriate, 
matching isotype Abs were used as controls. TG single-cell suspensions were passed through a 
40 µm filter-cap tube (BD Pharmingen) to remove debris. Ab surface staining was performed 
according to manufacturer’s instructions and as described previously (65). Flow cytometry was 
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performed on a BD FACSAria Cell Sorter using FACSDiva 4.1 or 5.0.2 software (BD 
Pharmingen). 
3.5.2 Flow-based T cell function assay 
For intracellular cytokine and granzyme B staining and lytic granule release determination, the 
BD Cytofix/Cytoperm kit with GolgiPlug™ was used following manufacturer’s protocol. 
GolgiPlug™ contains brefeldin-A, an inhibitor of protein trafficking through the trans-Golgi 
network. Thus, cells treated with brefeldin-A can synthesize, but not secrete, cytokines, allowing 
for the identification of cytokine-producing cells by intracellular flow cytometry. In short, TG 
suspensions were stimulated with B6WT3 fibroblasts pulsed with varying concentrations of 
gB498-505 peptide for varying lengths of time in the presence of GolgiPlug™ (65,227) and, in 
some instances, anti-CD107a Ab (218). Following stimulation, suspensions were labeled with 
appropriate surface antibodies as above. Samples were then washed in FACS buffer (1% FCS, 
0.1% NaN3 in PBS) and permeabilized with Cytofix/Cytoperm solution for 20 min on ice. 
Intracellular Abs were diluted in 1X BD Perm/Wash solution and incubated with samples for 30 
min on ice. After labeling, suspensions were washed with 1X Perm/Wash and resuspended in 
FACS buffer for analysis by flow cytometry. CD107a, a molecule on lysosomal and lytic granule 
membranes, is a marker of degranulation; it is briefly expressed on the cell surface following 
lytic granule membrane fusion to the cell membrane during release of lytic granules (228).  
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3.5.3 CFSE ex vivo proliferation assay 
Proliferation ex vivo was assayed by labeling TG suspensions with 2.5 µM carboxyfluorescein 
succinimidyl ester (CFSE; Molecular Probes, Eugene, OR) and incubating for 72 h with or 
without HSV-1 gB498-505. Samples were then labeled with surface antibodies as above and 
analyzed by flow cytometry. As each cell division reduces cytoplasmic CFSE labeling by half, 
CFSE dilution can be used to quantify cell proliferation and division.  
3.6 MEASURING APOPTOSIS  
3.6.1 Annexin-V labeling 
Mice were euthanized by perfusion with 1% paraformaldehyde (Sigma-Aldrich) in PBS. TG 
were excised, washed with PBS, and placed in one TG per well in a round-bottom 96-well plate, 
then incubated with PE-labeled anti-CD8α mAb (1 µg/ml), FITC-labeled Annexin-V (5 µl/TG; 
BD Pharmingen), and anti-CD16/CD32 (1:500), in 1X Annexin-V Binding Buffer (10X = 0.1 M 
HEPES, pH 7.4, 1.4 M NaCl, 25 mM CaCl2; BD Pharmingen) overnight at 4ºC on a shaker. 
Binding of Annexin-V to phosphatidylserine molecules on the outer leaflet of the cell membrane 
is a marker for apoptosis as phosphatidylserines are only expressed on the outer leaflet of the cell 
membrane during apoptosis.  
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3.6.2 Fluorescently-labeled inhibitor of caspase activation (FLICA) 
Single cell TG suspensions were incubated 1 h in serum-free media in the presence of FAM-
VAD-FMK (Chemicon, Temecula, CA) at 37ºC. The cells were then labeled with appropriate 
antibodies and analyzed by flow cytometry.  
3.6.2.1 FAM-VAD-FMK-based cytotoxicity assay 
Single cell TG suspensions were incubated with B6WT3 fibroblasts labeled with the 
lipophilic tracer DiI (Molecular Probes) that had been pulsed with varying concentrations of 
gB498-505 peptide or left nonpulsed for 6 h at 37ºC in the presence of FAM-VAD-FMK. After 6 h, 
the cells were stained with antibodies to CD8α and CD45, and then analyzed by flow cytometry.  
3.7 DNA ISOLATION FROM TG 
DNA was isolated from TG using the Qiagen DNAeasy™ Tissue Kit following the 
manufacturer’s protocol. In short, collagenase-treated TG were resuspended in 200 µl PBS per 
sample, then treated with 20 µl proteinase K and 200 µl Buffer AL, mixed thoroughly, and 
incubated 10 min at 70ºC on a dry bath incubator (Fisher Scientific). Samples were then treated 
with 200 µl 100% EtOH and transferred to a mini-spin column and centrifuged. The columns 
were treated with Buffer AW1 and Buffer AW2, with spins between each treatment, and finally, 
samples were eluted in 100 µl Nuclease-Free H2O (Ambion, Austin, TX). DNA was quantitated 
using a SpectraMax Plus 384 spectrophotometer (Molecular Devices, Sunnyvale, CA) using 
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SoftMax Pro 4.3 software (Molecular Devices) and 100 ng DNA per sample was resuspended to 
a 1 ng/ml concentration in nuclease-free H2O.   
3.7.1 Real-time PCR for glycoprotein H (gH) DNA 
25 ng of DNA or water control was mixed in duplicate with 25 µl of TaqMan Universal PCR 
Master Mix (Roche, Branchburg, NJ) and an HSV-1 glycoprotein H (gH)-specific primer-probe 
set, custom designed and synthesized by ABI Assays-by-Design service (Applied Biosystems, 
Foster City, CA). Samples (50 µl/well) were assayed in 96-well plates with an ABI Prism 7700 
sequence detector. ABI Primer Express v1.5a software default settings were used for instrument 
control and data analysis. The gH sequences were: forward primer (5’-
GACCACCAGAAAACCCTCTTT-3’), reverse primer (5’ACGCTCTCGTCTAGATCAAAGC-
3’), and probe [5’-(FAM)TCCGGACCATTTTC(NFQ)-3’]. The HSV-1 genome contains a 
single copy of the gH gene; therefore, viral genome copy number can be determined 
quantitatively by comparing the experimental CT value observed from the gH primer-probe assay 
with CT values of known concentrations of gH-containing plasmid standards (226).  
3.8 PREPARATION OF FROZEN TG SECTIONS 
TG were excised from PBS-perfused mice, embedded in optimal cryogenic temperature (OCT) 
compound (Tissue-Tek, Naperville, IL), snap-frozen in an acetone dry ice bath, and 6 µm 
sections were cut on a Cryostat 3050 S (Leica, Wetzlar, Germany) at -20ºC. The sections were 
then quickly fixed in acetone and stored at -20ºC until staining.  
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3.8.1 Immunohistochemistry 
Acetone-fixed 6 µm frozen TG sections were stained for HSV-1 Ags using a primary polyclonal 
rabbit anti-HSV-1 Ab (Accurate Chemical and Scientific) followed by goat anti-rabbit Ig 
secondary Ab, ABC reagent (Vectastain ABC, Vector Laboratories, Burlingame, CA), and 
detection with diaminobenzidine substrate (Vector Laboratories) as previously described (68). 
Sections were then dehydrated, mounted in Immu-mount (Thermo Electron, Waltham, MA), and 
covered with a coverslip. Stained sections were stored at -20ºC.  
3.9 IN VIVO TREATMENTS 
3.9.1 In vivo depletion of CD8+ T cells 
Latently infected mice received a single i.p. injection of 0.5 mg of anti-CD8α mAb (clone 2.43, 
rat IgG2b) three days before TG excision. 
3.9.2 BrdU in vivo proliferation assay 
Proliferation in vivo was assayed by injecting HSV-1 infected mice daily with 1 mg 5-bromo-2-
deoxyuridine (BrdU; Sigma-Aldrich) in 1X PBS. BrdU is a synthetic nucleoside analogue of 
thymidine; it incorporates into newly synthesized DNA strands and can then be detected with 
specific antibodies by flow cytometry (229).  
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3.9.3 Restraint Stress 
On 4 consecutive nights beginning at various times after infection, mice were physically 
restrained in a 50 ml conical tube containing approximately one hundred 0.4 cm-diameter holes.  
The 12 h restraint sessions in their home cages were begun 2 h into the dark cycle.  Each restraint 
session was followed by a 12 h period without restraint.  Since the stressed mice lacked access to 
food and water during the restraint sessions, nonstressed control mice were similarly food and 
water deprived, but not restrained. For experiments examining the effects of stress during 
latency, the stress paradigm was initiated at 9:00 PM, 30 d after infection (Figure 7); for 
experiments examining stress during the primary immune response, restraint was started 4 d after 
infection.  
 
Figure 7. Model of restraint stress during latency. 
Restraint stress was initiated on the evening prior to 31 d post infection and completed 
the morning of 34 d post infection. Figure adapted from (218), © The Journal of 
Immunology, used with permission.  
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3.9.4 Corticosterone treatment 
For 4 consecutive days beginning at various times after infection, mice were supplied with 400 
µg/ml corticosterone (MP Biomedicals, Irvine, CA) in the drinking water. Freshly made 
corticosterone was re-supplied every other day. Corticosterone was dissolved in 30% (2-
hydroxypropyl)-β-cyclodextrin (HBC; Sigma-Aldrich), prepared by dissolving 9 g HBC in 30 ml 
H2O. 100 mg corticosterone was then dissolved in 5 ml HBC and brought to 250 ml with H2O 
per treated group. Thus, if two treated groups were required, 200 mg corticosterone was 
dissolved in 10 ml HBC and brought to 500 ml with H2O.  
3.9.5 Nadolol treatment 
Mice were injected i.p. with 5 mg/kg nadolol (Sigma-Aldrich) in 500 µl PBS/0.2% EtOH per 
mouse beginning 1 d prior to stress, and continuing daily throughout the stress treatment, for a 
total of 5 injections per mouse. Control mice were treated with vehicle.  
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4.0  RESULTS 
4.1 CD8+ T CELL SURROUND SELECT NEURONS IN LATENTLY INFECTED TG 
Following establishment of a latent HSV-1 infection, CD8+ T cells remain in the TG for the life 
of the host (65,115). In humans, CD8+ T cells selectively surround neurons that are latently 
infected with HSV-1, but not varicella zoster virus (VZV) (115). As depicted in Figure 8, in our 
murine corneal infection model, we observe CD8+ T cells (red) surrounding some neurons 
(green), but not others. Some of these CD8+ T cells polarize their TCR in an apparent immune 
synapse with the neuron (65).  
 
Figure 8. CD8+ T cells surround some neurons in latently infected TG.  
TG whole mounts were stained with anti-CD8α and examined by confocal microscopy. 
CD8+ T cells (red) surround particular neurons (green) in latently infected TG 34 d p.i. 
Magnification 60X. 
 49 
4.2 CD8+ T CELLS ARE REQUIRED IN VIVO TO PREVENT VIRAL DNA 
SYNTHESIS 
Although HSV-specific CD8+ T cells block HSV-1 reactivation from latency in ex vivo 
TG cultures (64,65), a similar protective function has not been established in vivo.  Here we 
show that within 3 d of a single injection of anti-CD8α mAb, CD8+ T cells were effectively 
depleted from mouse TG that harbored latent HSV-1 (Figure 9A), and the HSV-1 genome copy 
number in the TG was significantly increased (Figure 9B).  Thus CD8+ T cells actively monitor 
latent HSV-1 in sensory neurons and inhibit replication of the viral genome.   
 
 Figure 9. CD8+ T cells are required to prevent viral DNA synthesis.  
Thirty days after HSV-1 corneal infection mice harboring latent virus in their trigeminal 
ganglia (TG) received a single i.p. injection of anti-CD8α mAb. 3 d after treatment TG 
were excised from CD8-depleted and non-depleted mice and dispersed cells were 
analyzed by flow cytometry for their expression of CD8α and CD8β. (A) Dot plots 
demonstrate a lack of CD8+ T cells in TG of anti-CD8α mAb treated mice, gated on 
CD45+ cells. (B) DNA from ganglia of CD8-depleted mice (n = 5) contained a 
significantly (p< 0.009, Student’s t test) higher viral genome copy number than that from 
non-depleted mice (n = 20) when analyzed by quantitative real-time PCR for the HSV-1 
glycoprotein H gene. Figure adapted from (218), © The Journal of Immunology, used 
with permission. 
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4.3 STRESS OR GLUCOCORTICOID TREATMENT INCREASE SERUM LEVELS 
OF CORTICOSTERONE 
The effectiveness of a stress response can be measured by elevated serum levels of HPA-derived 
glucocorticoids. Our stress protocol (as illustrated in Figure 7) uniformly elevated serum levels 
of corticosterone (Figure 10, left graph). Direct treatment with 400 µg/ml corticosterone in the 
drinking water increased serum levels of corticosterone to levels that were significantly greater 
than levels induced by stress (Figure 10, right graph).  
 
Figure 10. Elevated serum levels of corticosterone following stress or glucocorticoid 
treatment.  
 
(A) Sera of nontreated (n = 12) mice or mice that were food and water deprived (FWD) 
but not stressed (nonstressed, n = 14) contained significantly (p<0.0001, one-way 
ANOVA and Tukey’s post test) less corticosterone (CORT) than sera from stressed (n = 
4) mice when analyzed by a standard radioimmunoassay. ns, not significant. (B) Sera of 
corticosterone treated (n = 10) mice contained significantly more corticosterone than 
nontreated (n = 10) mice. *** p <0.0001, Student’s t test. Adapted from (218), © The 
Journal of Immunology, used with permission.  
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4.4 EFFECTS OF RESTRAINT STRESS ON HSV-1 REACTIVATION 
Since stress inhibits CD8+ T cell function and induces HSV-1 reactivation, we 
hypothesized that reactivation results at least in part from a stress-induced transient compromise 
in the immunosurveillance capability of CD8+ T cells within latently infected TG.  To test this 
hypothesis, latently infected mice were subjected to four, 12-h restraint sessions as illustrated in 
Figure 7.  That this stress protocol influenced the state of viral latency was established by an 
approximate 2-fold increase in the viral genome copy number in DNA from TG of stressed 
relative to non-stressed mice (Figure 11A), similar to the increased copy number observed 
following CD8+ T cell depletion (Figure 9B).   
Stress-induced reactivation was further established by direct ex vivo detection of 
infectious HSV-1 in 1 of 8 stressed TG, and detection of HSV-1 proteins in serial sections of 1 of 
4 stressed TG (Figure 11B and data not shown).  Neither infectious virus nor HSV-1 proteins 
were detected in any nonstressed TG tested. The inconsistent detection of replicating virus in the 
presence of uniformly elevated viral genome copy number probably reflects the enhanced 
sensitivity of viral DNA detection by real time PCR relative to detection of infectious virions on 
monolayers of susceptible cells (230).  
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 Figure 11. Restraint stress during latency increases HSV-1 genome copy number in 
the TG. 
 
(A) TG were excised from stressed and non-stressed mice at the indicated time after 
infection and the HSV-1 genome copy number was determined by real-time PCR. ** p = 
0.0039, Student’s t test. (B) Frozen sections of TG obtained from stressed and 
nonstressed mice at 34 d after infection and stained for HSV-1 antigens. Arrows identify 
regions of positive staining for HSV-1 antigens. Figure adapted from (218), © The 
Journal of Immunology, used with permission. 
 
Although observation of stress-induced reactivation in vivo by real-time PCR was 
particularly clear, stress-induced reactivation in ex vivo TG cultures was less obvious. When 
HSV-1 pgB-EGFP-infected TG were excised and plated in one-tenth TG/well cultures in a 96-
well plate, we observed a slight increase in the percentage of cultures that showed reactivation, 
as measured by spread of fluorescence (Figure 12A). However, maximum reactivation was only 
about 10% of the cultures, making any differences between stressed and nonstressed cultures 
hard to discern. Using one-fifth TG/well cultures in a 48-well plate from mice infected with 
HSV-1 pgB-EGFP-pgC-mRed, we observed a greater increase in the percentage of cultures that 
were positive for reactivation, but again, differences between the groups were quite small (Figure 
12B). Although there was a trend for higher reactivation rates in stressed cultures, in neither of 
these strategies to measure reactivation did we observe significant differences between 
nonstressed and stressed groups. Importantly, in neither of these conditions were the cultures 
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from stressed TG continuously exposed to stress hormones that would otherwise be present in 
vivo. Thus, these experimental designs may underestimate the stress-induced reactivation 
frequency. Additionally, although these cultures were pooled from several ganglia, the potential 
remains that repetition of these experiments could result in greater, biologically and statistically 
significant effects.  
 
Figure 12. Reactivation in ex vivo TG cultures. 
TG were excised from mice at 34 d p.i. that were latently infected with recombinant 
HSV-1 reporter virus and either stressed (solid squares, n = 40-90) or nonstressed (open 
squares, n = 40-84). (A) Rate of reactivation as measured by spread of fluorescence in 0.1 
TG/well cultures. Mice were infected with HSV-1 pgB-EGFP. Data is from one 
experiment. (B) Rate of reactivation as measured by spread of fluorescence in 0.2 
TG/well cultures. Mice were infected with HSV-1 pgB-EGFP/pgC-mRed. Data is pooled 
from two experiments, error bars are not shown.  
 
CD8+ T cells block HSV-1 reactivation through IFN-γ and lytic granule exocytosis in an 
MHC-restricted fashion (52,60,148,177). IFN-γ blocks reactivation in some, but not all, neurons 
that require T cell protection and this phenomenon correlates with the expression of IFN-γ 
receptor (IFN-γR) on a proportion of neurons (231). The nonclassical MHC-I molecule Qa-1b 
inhibits CD8+ T cell killing of infected neurons: blocking Qa-1b interactions with its receptor on 
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T cells, NKG2A/CD94, allowed for the T cell-mediated destruction of those neurons in an in 
vitro cytotoxicity assay (148). Therefore, we examined the effects of stress on neuronal 
expression of IFN-γR and Qa-1b. Interestingly, we observed no overt qualitative differences in 
the expression of either of these two molecules on neurons in latently infected TG following 
stress (Figure 13). These data suggest that the stress-induced increase in viral genomes is not due 
to an impairment of the ability of latently infected neurons to respond to the protective capacities 
of T cells. However, this assay is qualitative, not quantitative, and at this time the conclusion is 
still tentative. 
 
Figure 13. Effects of stress on neuronal expression of IFN-γR and Qa-1b. 
Whole TG from stressed or nonstressed mice were washed, fixed in 1% PFA, and labeled 
with antibodies to IFN-γ receptor (IFN-γR) or the nonclassical MHC-Ib molecule Qa-1b 
and examined by confocal microscopy. Magnification 40X. 
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4.5 EFFECTS OF RESTRAINT STRESS ON T CELLS IN THE TG 
4.5.1 Stress reduces CD8+ and CD4+ T cells in latently infected TG 
The increased viral copy number was associated with a 30% reduction in the number of CD8+ T 
cells within the TG of stressed mice (Figure 14A). This reduction was transient and by 2 d after 
stress cessation CD8+ T cell numbers returned to nonstressed levels (data not shown). A similar 
reduction was observed in the spleen (data not shown), indicating that the effects of stress were 
systemic and not limited to the TG. Most, if not all, HSV-specific CD8+ T cells in latently 
infected TG of C57BL/6 mice are specific for the gB498-505 epitope and can be quantified by 
staining dispersed TG-derived immune cells with tetramers containing this H-2Kb restricted 
epitope followed by flow cytometric analysis (65). Tetramer staining of CD8+ T cells revealed a 
similar frequency of gB498-505-specific CD8+ T cells in the TG of stressed and nonstressed mice 
demonstrating that stress did not selectively deplete HSV-specific CD8+ T cells (Figure 14B). 
Similar results were determined using gB498-505 loaded dimers (data not shown). Given similar 
frequencies of virus-specific cells, but an overall reduction in total CD8+ T cell number in the 
TG, the absolute number of TG-resident HSV-specific CD8+ T cells was reduced by 30% 
following stress.  
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 Figure 14. Restraint stress reduces CD8+ T cell number in latently infected TG. 
Latently infected mice were subjected to restraint stress as described in Figure 7. After 
the fourth restraint stress session (34 d after infection) TG were excised from stressed and 
nonstressed mice, dispersed into single cell suspensions, and simultaneously stained with 
anti-CD8α mAb and tetramers containing the immunodominant HSV-1 gB498-505 epitope 
(gB498-505 H-2Kb). (A) The mean absolute number of CD8+ T cells/TG (± SEM) in 
stressed (n = 23) and non-stressed (n = 16) mice. * p = 0.03, Student’s t test. (B) Percent 
of CD8+ T cells that recognize the gB498-505 epitope. Group differences were not 
significant (p = 0.1436, Student’s t test). Figure adapted from (218), © The Journal of 
Immunology, used with permission. 
 
 TG-resident CD8+ T cells express high levels of CD44, a marker for activated and 
memory cells, and CD69, an early activation marker (65). The frequency of CD44+ memory 
CD8+ T cells was slightly increased, but this result, while statistically significant, is of 
questionable physiological relevance (Figure 15A). Expression of CD69, although consistently 
elevated, was not significantly different (Figure 15B).  
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 Figure 15. Activation phenotype of CD8+ T cells in the TG after stress. 
TG-resident CD8+ T cells from stressed (n = 8-11) and nonstressed (n = 8-9) mice were 
assayed for cell surface expression of CD44 (A) and CD69 (B) by flow cytometry. 
Representative dotplots show the CD45+ population. Numbers in the top right quadrant 
are percent of CD8+ T cells that are positive for the given molecule. Graphs on the right 
are values pooled from 2 experiments. *** p < 0.001. ns = not significant, Student’s t 
test. 
 
The number of CD4+ T cells is reduced approximately 30% following restraint stress, and 
like CD8+ T cells, the reduction is transient (Figure 16, and data not shown). Although the 
antigen specificity of the CD4+ T cell population is unknown, we examined the cells for 
expression of known activating and inhibitory receptors (Figure 17). There was a slight tendency 
toward a more activated phenotype (increased expression of activating receptors and decreased 
expression of inhibitory receptors), but there were no statistical differences from controls in the 
remaining cells. The presence of regulatory T cells (Tregs) was also unchanged, based upon 
intracellular expression of the transcription factor FoxP3 (Figure 17E).  
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 Figure 16. Restraint stress reduces CD4+ T cell number in the latently infected TG.  
Latently infected mice were subjected to restraint stress as described in Figure 7. After 
the fourth restraint stress session (34 d after infection) TG were excised from stressed and 
nonstressed mice, dispersed into single cell suspensions, and simultaneously stained with 
anti-CD4 mAb The mean absolute number of CD4+ T cells/TG (± SEM) in stressed (n = 
20) and non-stressed (n = 16) mice. * p = 0.04, Student’s t test.  
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 Figure 17. Phenotype of CD4+ T cells after stress. 
TG-resident CD4+ T cells from stressed (n = 8) and nonstressed (n = 8) mice were 
assayed for cell surface or intracellular expression of CD25 (A), CD69 (B), CD44 (C), 
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NKG2D (D), FoxP3 (E), PD-1 (F), CTLA-4 (G), or NKG2A (H) by flow cytometry. 
Representative dotplots show the CD45+ population. Numbers in the top right quadrant 
are percent of CD4+ T cells that are positive for the given molecule. Graphs on the right 
are values pooled from 2 experiments. ns = not significant, Student’s t test.  
4.5.2 HSV-specific CD8+ T cells that are retained in the TG following stress are 
functionally compromised 
In our model, HSV-1 begins to reactivate from latency in ex vivo TG cultures within the 
first 72 h of incubation (Figures 12 and 18), and reactivation can be inhibited by gB498-505-
specific CD8+ T cells (65).  Reactivating neurons present viral antigenic epitopes to T cells, but 
the amount of MHC-restricted viral epitopes presented is far less than the T cells are capable of 
recognizing. In vivo, the low level of antigen presentation during latency or at the beginning of 
reactivation is recognized and full reactivation to virion formation can be prevented. In cultures, 
however, a discrepancy develops between the magnitude of the T cell response to reactivating 
neurons and the T cell response to optimal stimulation by addition of exogenous peptide. Despite 
this, detailed observations can be made distuingishing stress-mediated effects at low densities of 
epitope versus a maximum response. Therefore we tested the effects of in vivo stress on the 
functional capabilities of TG-resident CD8+ T cells during a 72 h incubation of latently infected 
TG alone (latently infected neurons are the only source of viral antigens) or when an optimal 
stimulatory dose of gB498-505 peptide was added to the TG cultures. Two main functions of 
memory T cells in response to antigen are cytokine production and proliferation. Latently 
infected TG obtained from stressed and non-stressed mice were dispersed into single-cell 
suspensions, stained with CFSE, and cultured for 72 h with or without gB498-505 peptide.  The 
cells were then removed from culture, stained with anti-CD8α mAb, and CD8+ T cells were 
analyzed by flow cytometry for proliferation as assessed by CFSE dilution.   
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 Figure 18. Viral late (γ1) gene expression in ex vivo TG cultures.  
TG cultures from mice latently infected with HSV-1 pgB-EGFP/pgC-mRED were 
incubated for 48 h then imaged. Magnification 40X. 
 
 
Figure 19A shows a representative dot plot in which cells that underwent one or more 
rounds of proliferation are gated and the mean fluorescence intensity (MFI) of proliferated cells 
is indicated for a rough comparison of the number of rounds of proliferation these cells 
underwent in the various groups. In cultures of non-stressed TG approximately 50% of CD8+ T 
cells proliferated during the 72 h incubation in the presence or absence of gB498-505 peptide.  In 
contrast, significantly fewer CD8+ T cells in stressed TG proliferated in response to reactivating 
virus (Figure 19B). The addition of gB498-505 peptide to stressed TG cultures increased CD8+ T 
cell proliferation slightly (28% no peptide, 41% with peptide), but even in the presence of added 
peptide fewer CD8+ T cells in stressed TG proliferated when compared to similarly stimulated 
CD8+ T cells in non-stressed TG (Figure 19C). Moreover, those CD8+ T cells in stressed TG that 
did proliferate in response to peptide underwent fewer rounds of proliferation than their 
counterparts in non-stressed TG as indicated by higher MFI (Figure 19C).   
A very low frequency (< 2%) of TG resident CD8+ T cells expressed detectable 
intracellular IFN-γ when tested directly ex vivo. However, when dispersed cells from latently 
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infected TG were incubated for 72 h, IFN-γ production was induced in approximately 10% of 
CD8+ T cells in non-stressed TG. In contrast, IFN-γ production by CD8+ T cells in stressed TG 
was not significantly increased during the 72 h incubation, and was significantly lower than that 
of their counterparts in nonstressed TG (Figure 19D). The addition of gB498-505 peptide to 
cultures greatly augmented IFN-γ production such that 40% of CD8+ T cells in both stressed and 
non-stressed TG were IFN-γ positive (Figure 19E). These findings are consistent with the 
tetramer staining results showing a similar frequency of HSV-1 gB498-505 specific CD8+ T cells in 
the TG of stressed and non-stressed mice, but demonstrate that CD8+ T cells in stressed TG are 
compromised in their ability to produce IFN-γ in response to viral reactivation in neurons.   
 
Figure 19. Stress compromises the function of HSV-specific CD8+ T cells in latently 
infected TG. 
 
TG were excised from stressed and non-stressed mice, dispersed into single cell 
suspensions, and incubated for 72 h. TG cells were stained with CFSE and cultured with 
or without added HSV-1 gB498-505 peptide. After incubation the cells were stained with 
anti-CD8α mAb and CFSE staining intensity of CD8+ T cells was analyzed by flow 
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cytometry. (A) Representative dot plots show the extent of CFSE dilution in stressed and 
non-stressed cultures, gated on CD45+CD8+ cells. The box designates cells that have 
undergone one or more rounds of cell proliferation, and the mean fluorescence intensity 
(MFI) of these cells is shown. (B/C) Data are presented as the mean (± SEM) percentage 
of CD8+ T cells that underwent one or more rounds of proliferation, and MFI of 
proliferating cells in cultures without peptide (B, n = 8/group) or with added peptide (C, 
n = 13-14/group).  (D) Single cell suspensions of TG from stressed and non-stressed mice 
were incubated directly ex vivo for 6 h without stimulation in the presence of 
GolgiPlug™ (directly ex vivo, n=3-4/group), or were cultured for 72 h and received 
GolgiPlug™ (TG culture, n = 13-17/group) for the last 6 h of incubation, stained for 
surface CD8 and intracellular IFN-γ, and analyzed by flow cytometry. Data are presented 
as the mean (± SEM) percentage of IFN-γ positive CD8+ T cells. * p<0.05. (E) Cultures 
received HSV-1 gB498-505 peptide (n = 4/group) and GolgiPlug™ for the last 6 h of the 72 
h incubation, were stained for surface CD8α and intracellular IFN-γ, and analyzed by 
flow cytometry. Data are presented as the mean (± SEM) percentage of IFN-γ positive 
CD8+ T cells. ** p<0.01, all data were analyzed with Student’s t test. Figure adapted 
from (218), © The Journal of Immunology, used with permission. 
 
 
The reduced IFN-γ production in response to latently infected neurons alone could reflect 
either an intrinsic compromise in the function of the CD8+ T cells in stressed TG or an extrinsic 
effect such as less antigen production and presentation by neurons in stressed TG. To eliminate 
possible extrinsic effects, mixed cultures of latently infected TG from stressed (CD45.1) and 
non-stressed (CD45.2) congenic mice were employed (illustrated in Figure 20). In these mixed 
TG cultures, CD8+ T cells from stressed and nonstressed mice experienced identical antigenic 
exposure, and could be identified based on expression of different CD45 alleles. As illustrated in 
Figure 21A, 40% fewer CD8+ T cells from stressed than nonstressed TG produced IFN-γ in 
response to identical exposure to reactivating virus. However, when an optimal stimulatory dose 
of the gB498-505 peptide was added to the mixed cultures the percentage of IFN-γ producing CD8+ 
T cells was increased and the effect of stress on IFN-γ production was lost (Figure 21B). Thus, 
the reduced response of CD8+ T cells from stressed mice does not reflect a reduced frequency of 
HSV-specific CD8+ T cells or altered antigenic expression by stressed neurons, but rather 
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appears to result from a stress-induced functional compromise that can be overcome by addition 
of gB498-505 peptide to cultures.     
 
Figure 20. Experimental design for experiments shown in Figure 21 
Illustration of the preparation of mixed TG cultures from stressed (CD45.1) and 
nonstressed (CD45.2) latently infected congenic mice. Figure adapted from (218), © The 
Journal of Immunology, used with permission. 
 
 
 
Figure 21. CD8+ T cells in stressed mice exhibit an intrinsic compromise of IFN-γ 
production.  
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Congenic mice were infected with HSV-1 and 30 d later were stressed or not, TG were 
obtained and dispersed into single cell suspensions, and mixed cultures of TG from 
stressed and non-stressed mice were prepared as depicted. After 90 h, GolgiPlug™ was 
added to cultures without (A) or with (B) HSV-1 gB498-505 peptide for the last 6 h of 
incubation. Cells were recovered from cultures, surface stained with anti-CD8α and anti-
CD45.1 mAb followed by intracellular stain for IFN-γ. Representative dot plots show 
recovery of CD8+ T cells that originated from stressed (CD45.1) and non-stressed 
(CD45.2) TG from the mixed cultures, and IFN-γ expression in each population. Percents 
in lower right corner indicate the percentage of CD8+ T cells in the gated population. The 
graph shows the mean (± SEM) percentage of CD8+ T cells from stressed and 
nonstressed TG that expressed IFN-γ in the mixed TG cultures (n = 18). Data were 
analyzed with a Student’s paired t test. Figure adapted from (218), © The Journal of 
Immunology, used with permission. 
 
4.5.3 There is no extrinsic stress-induced deficiency. 
Initial experiments suggested there might be an extrinsic effect of stress in addition to the 
intrinsic effect described above. Neurons from stressed TG (potentially undergoing active viral 
reactivation), or other stress-susceptible cells, could potentially secrete repressive molecules that 
might interfere with the function of the CD8+ T cells. Subsequent experiments suggest otherwise, 
however, as IFN-γ production at 72 h in nonstressed cultures alone occurred in 10.4% of CD8+ T 
cells (Figure 19D), and in mixed cultures at 96 h, 14.12% of the nonstressed cells synthesized 
IFN-γ (Figure 21A). The lack of a TG culture-mediated extrinsic effect was confirmed by 
directly comparing the IFN-γ response in TG cultures with or without CD8-depleted TG from 
stressed mice (Figure 22). Stressed TG were labeled with CFSE and then depleted of CD8+ T 
cells by positive selection with magnetic beads. TG cultures from nonstressed mice were then 
mixed with CD8-depleted cultures, or cultured alone. Cultures were then assayed for IFN-γ 
synthesis during the final 6 h of a 72 h incubation as above. By depleting endogenous CD8+ T 
cells before mixing the cultures, we were able to evaluate whether other components of the 
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stressed culture could influence the CD8+ T cell response from nonstressed TG. We observed no 
difference in IFN-γ synthesis between nonstressed cultures alone or nonstressed cultures mixed 
with CD8-depleted stressed TG (Figure 22).  
 
Figure 22. Stressed TG culture does not affect the nonstressed CD8+ T cell response. 
Stressed TG were labeled with 2.5 µM CFSE, depleted of CD8+ T cells, then mixed with 
unlabeled nonstressed TG with or without 10-12M gB498-505 peptide. Cultures were 
incubated with GolgiPlug™ during the last 6 h of a 72 h incubation, then measured for 
IFN-γ by flow cytometry. Representative dotplots on the left show the extent of CD8 
depletion. Numbers in top left quadrant indicate percentage of CD8+ T cells in that 
quadrant. Representative dotplots on the right show IFN-γ production. Numbers in top 
right quadrant indicate percentage of CD8+ T cells in that quadrant. Graph on the right 
shows the percentage of CD8+ T cells that are IFN-γ+. Nonstressed, nonstressed alone (n 
= 1), Mixed, CD8-depleted stressed TG plus nonstressed TG (n = 6), Mixed + peptide, 
similar to mixed, but with added gB498-505 peptide.  
 
The lack of extrinsic effect by the stressed TG culture is consistent with the observation 
that FoxP3+ Tregs, important regulators of T cell function, were present at a similar frequency in 
ganglia of stressed and nonstressed mice (Figure 17E). Had Tregs been selectively retained in 
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stressed TG, there may have been a better case for an extrinsic effect. These data also imply that 
reactivating virus does not inhibit the response of surveillance memory CD8+ T cells.  
4.5.4 Cytokine response is dysregulated at low epitope densities.  
Our previous studies revealed that CD8+ T cells in stressed TG responded normally to optimal 
stimulation with gB498-505 peptide, but exhibited an intrinsic defect in response to neurons 
harboring latent virus. Since latently infected neurons likely express low levels of viral 
proteinsand low MHC class I, we hypothesized that CD8+ T cells in TG of stressed mice 
required a higher threshold of antigen stimulation than their counterparts in nonstressed TG. To 
test this, we recapitulated the effects of epitope density in vitro by stimulating stressed or 
nonstressed CD8+ T cells with fibroblasts pulsed with varying concentrations of gB498-505 epitope 
(Figure 23A). At 10-12 M gB-peptide concentration, stressed CD8+ T cells responded 88.5% as 
well as nonstressed controls, dropping to 78.2% at 10-18 M, and 68.5% at 10-22 M.  
 
Figure 23. Cytokine response is compromised at low epitope densities. 
TG from stressed or nonstressed mice were incubated for 6 h with B6WT3 fibroblasts 
pulsed with indicated concentrations of gB498-505 peptide in the presence of GolgiPlug™. 
(A) The percentage of CD8+ T cells from stressed TG that synthesized IFN-γ is shown as 
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a percentage (± SEM) of the nonstressed response at each peptide concentration. 10-12M 
(n = 5), 10-18M (n = 3), 10-22M, (n = 2). (B) The percentage of CD8+ T cells from stressed 
TG that synthesized TNF-α is shown as in part (A). 10-12M, (n = 3), 10-18M, (n = 3), 10-
22M, (n = 2).  
 
Synthesis of the cytokine TNF-α was also measured. As with IFN-γ, TNF-α production 
is optimal at 10-12 M gB-peptide concentration (67). Following stress, the CD8+ T cell ability to 
produce TNF-α was impaired, dropping from 84.9% of nonstressed controls at 10-12 M to 61.5% 
at 10-22 M (Figure 23B).  
We also measured the cytokine response in vivo during the last 12 h of stress. Using a 
modified protocol of the in vivo brefeldin-A treatment used by Liu and Whitton (232), we 
injected 250 mg brefeldin-A i.p. at 12- and 6 h prior to sacrifice assess IFN-γ and TNF-α 
synthesis in vivo (Figure 24). We observed a 6.67-fold reduction in IFN-γ production and a 7.24-
fold reduction in TNF-α synthesis in the stressed group. It should be noted that the response was 
very low. However, at any given time, very few neurons are expressing viral antigens in normal 
ganglia (38), and thus, the amount of CD8+ T cells that would be producing cytokines in 
response to viral antigens would necessarily be quite low.  
Together, the preceding data show that stress compromises the memory CD8+ T cell 
response at physiological concentrations of viral antigens.  
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 Figure 24. In vivo cytokine production during stress. 
Mice were treated with 250 mg/mouse brefeldin-A i.p. at 12- and 6 h  prior to sacrifice, 
during the final session of stress. The percentage (± SEM) of CD8+ T cells in the TG that 
was positive for intracellular IFN-γ or TNF-α was measured by flow cytometry. All 
groups, n = 3. ** p = 0.0058. * p = 0.0170, Student’s t test.  
 
4.5.5 Stress impairs CD8+ T cell ability to degranulate 
Lysosomal associated membrane protein-1 (LAMP-1 or CD107a), is a protein embedded in the 
membranes of intracellular vesicles, including lytic granules. During exocytosis of these vesicles, 
CD107a is briefly expressed on the surface of the cell, where it can be labeled by antibody and 
assayed by flow cytometry. Labeling CD107a identifies cells that have recently degranulated and 
has been correlated lysis of target cells by both CD8+ T cells and NK cells (228,233,234). In 
addition to synthesizing IFN-γ and TNF-α, TG-resident memory CD8+ T cells have been shown 
to express CD107a on their cell surface during stimulation with peptide-pulsed target cells (67).  
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 Figure 25. Stress impairs CD107a expression and granzyme B release. 
Latently infected TG were excised from stressed or nonstressed mice and (A) assayed for 
surface expression of CD8, CD45, and CD107a by flow cytometry either directly ex vivo 
or for the last 6 h of a 72 h incubation. Directly ex vivo (n = 1 for both groups), 72 h 
culture (nonstressed, n = 14; stressed, n = 20). ** p = 0.0038, Student’s t test. (B) TG 
were incubated for 6 h with 10-12M peptide-pulsed B6WT3 fibroblasts and measured for 
CD8, CD45, and CD107a. Numbers in top right quadrant indicate percentage of CD8+ T 
cells that expressed CD107a. (C) The percentage of CD8+ T cells from stressed TG that 
upregulated surface CD107a is shown as a percentage (± SEM) of the nonstressed 
response at each peptide concentration. 10-12M (n = 4), 10-18M (n = 3), 10-22M, (n = 2). 
 
Expression of CD107a is negligible on the cell surface of TG-resident CD8+ T cells 
directly ex vivo. Approximately 10% of the CD8+ T cells upregulate CD107a from 66 to 72 h in 
culture in nonstressed controls, but this upregulation is not observed in cultures from stressed 
ganglia (Figure 25A). During 6 h of optimal stimulation, approximately 50% of CD8+ T cells in 
the TG produce IFN-γ and express CD107a (67). As observed with IFN-γ synthesis (Figure 19E 
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and Figure 21B), stress had no effect of CD107a expression during optimal stimulation (Figure 
25B). Reducing the antigen density revealed a functional compromise in degranulation; at an 
epitope density of 10-22M, CD8+ T cells from stressed TG degranulated only 73% as much as 
their nonstressed counterparts (Figure 25C).  
A major component of preformed lytic granules is the serine protease granzyme B (235). 
Approximately 50% of virus-specific CD8+ T cells in the TG contain intracellular granzyme B 
(148). Based on the deficit in lytic granule release by CD8+ T cells in TG of stressed mice 
(Figure 25), we hypothesized that we would see a corresponding reduction in intracellular 
granzyme B. However, the amount of granzyme B strored in each cell increased significantly in 
the TG of stressed mice: the mean fluorescent intensity (MFI) of intracellular granzyme B was 
increased 80% following stress (Figure 26) in the virus-specific population, indicating that stress 
caused an accumulation of granzyme B within CD8+ T cells. This accumulation could be due to 
proper granzyme B synthesis coupled with impaired granule release shown in Figure 25.  
 
Figure 26. Increase in intracellular granzyme B MFI following stress. 
TG were excised from latently infected stressed or nonstressed mice were labeled with 
anti-CD8α, anti-CD45, and gB498-505/H-2Kb tetramers. Cells were then permeabilized and 
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measured for intracellular granzyme B by flow cytometry. Graph depicts the relative 
mean fluorescence intensity (MFI, ± SEM) of granzyme B antibody in the CD8+tetramer+ 
population. Nonstressed, n = 12, stressed, n = 12. * p = 0.0154, Student’s t test.  
  
Interestingly, granzyme B also accumulated within the gB-nonspecific CD8+ T cell population 
(Figure 27). Much fewer gB-nonspecific CD8+ T cells express granzyme B than gB-specific T 
cells, and the amount of granzyme B per cell is much less, demonstrating the efficacy of 
granzyme B as a marker for antigen-mediated activation versus other activation markers, such as 
CD69. As such, the granzyme B+ gB-nonspecific cells could potentially represent a population of 
HSV-specific cells that recognize an as-of-yet undefined epitope. Regardless, as both gB-specific 
and gB-nonspecific cells accumulated granzyme B following stress, expression of granzyme B as 
a percentage of the population also increased slightly (Figure 28), albeit nonsignificantly.  
 
 
Figure 27. Stress increases granzyme B in the gB-nonspecific population.  
TG were excised from latently infected stressed or nonstressed mice were labeled with 
anti-CD8α, anti-CD45, and gB498-505/H-2Kb tetramers. Cells were then permeabilized and 
measured for intracellular granzyme B by flow cytometry. Graph depicts the relative MFI 
(± SEM) of granzyme B antibody in the CD8+tetramerneg population. Nonstressed, n = 
12, stressed, n = 12. ** p = 0.0044, Student’s t test.  
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 Figure 28. Stress increases the percentage of granzyme B+ CD8+ T cells. 
TG were excised from latently infected stressed or nonstressed mice were labeled with 
anti-CD8α, anti-CD45, and gB498-505/H-2Kb tetramers. Cells were then permeabilized and 
measured for intracellular granzyme B by flow cytometry. Graph depicts the mean (± 
SEM) percentage of the CD8+ population that is positive for intracellular granzyme B. 
Nonstressed, n = 12, stressed, n = 12. p values determined by Student’s t test.  
 
 CD107a expression is correlated with cytotoxicity (233). Restraint stress during primary 
infection has been shown to impair the cytotoxic function of T cells in the DLN, and this 
compromise is dependent on signaling through β-adrenergic receptors (203). During latency, 
restraint stress has been shown to compromise cytotoxicity by HSV-specific splenocytes (223). 
At low epitope densities, we observed a deficiency in the ability of TG-resident CD8+ T cells to 
degranulate (Figure 25C). To directly relate CD107a expression with cytotoxic function within a 
small population of cells, we developed a novel flow-based cytotoxicity assay, fibroblasts 
labeled with the fluorescent membrane dye DiI are pulsed with varying concentrations of gB498-
505 peptide, then incubated for 6 h with TG cells in the presence of FAM-VAD-FMK, a 
fluorescently-labeled, cell permeable, non-cytotoxic molecule that binds activated caspases and 
inhibits their function (236). As the cells undergo caspase-mediated apoptosis they take up the 
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reagent, blocking their death and rendering them fluorescent (Figure 29). This assay will allow 
for the simultaneous measurement of apoptosis in target cells and CD107a expression by CD8+ T 
cells.  
This assay, currently still in development, should provide an excellent new tool with 
which to assess the cytotoxic potential of virus-specific CD8+ T cells in the latently-infected TG.  
 
Figure 29. The FAM-VAD-FMK cytotoxicity assay. 
gB498-505-specific CD8+ T cells were incubated with DiI-labeled B6WT3 fibroblasts 
pulsed with varying concentrations of gB498-505 peptide for 6 h at a 1:1 effector to target 
ratio, with or without added ethanol, in the presence of FAM-VAD-FMK, a 
fluorescently-labeled inhibitor of caspase activation that binds activated caspases. 
Representative histograms show the percentage of fibroblasts that were postitive for 
incorportation of the FAM-VAD-FMK reagent. Control, 5% Ethanol (EtOH), 10% EtOH 
(n = 1 each), no peptide, 10-18M, 10-12M (n = 2 each).  
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4.5.6 T cell effector functions time course 
At the optimal stimulatory dose of peptide, stressed T cells could respond as well as nonstressed 
controls by both IFN-γ production and degranulation (Figure 19E and Figure 21B). However, 
IFN-γ production and degranulation were measured at a single time (6 h of stimulation) leaving 
open the possibility that stress affects the rate of cytokine production or lytic granule exocytosis, 
potentially important for the ability of CD8+ T cells to block reactivation prior to virion 
synthesis. To address this possibility, CD8+ T cells from stressed or control mice were stimulated 
with fibroblasts pulsed with 10-12 M gB-peptide and examined at varying times within the 6 h 
assay. The percentage of cells that responded by expressing CD107a and synthesizing IFN-γ was 
similar between stressed and nonstressed TG at all time points examined (Figure 30A). Thus, at 
the optimal stimulatory concentration of peptide, stressed T cells were indeed as efficient at 
effector functions as controls. Interestingly, CD8+ T cells that produced IFN-γ had all initiated 
production by 2 h of stimulation (Figure 30B), whereas degranulation continued steadily 
throughout the 6 h assay (Figure 30C).  
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 Figure 30. Time course of effector functions after stress.  
TG were excised from stressed or nonstressed latently infected ganglia, incubated for 
varying times with 10-12M peptide pulsed B6WT3 fibroblasts in the presence of 
GolgiPlug™ and anti-CD107a, labeled with anti-CD8α and anti-CD45, permeabilized, 
labeled with anti-IFN-γ and analyzed by flow cytometry. (A) Representative dot plots 
gated on CD8+ T cells. Numbers in top right corner indicate percentage of CD8+ T cells 
that are positive for both IFN-γ production and CD107a expression. (B) Graph depicts the 
percentage of CD8+ T cells that produce IFN-γ as a percentage of the maximum response. 
(C) Graph depicts the percentage of CD8+ T cells that express CD107a as a percentage of 
the maximum response.  
 
4.5.7 Increase in apoptosis potential following restraint stress 
The 30% reduction in CD8+ T cell number after restraint stress could be due to several 
mechanisms, two of which are in situ apoptosis and migration out of the TG. Apoptosis of the 
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TG-resident CD8+ T cells was measured by incubating single-cell TG suspensions with FAM-
VAD-FMK for 1 h in serum-free media directly ex vivo. gB-specific CD8+ T cells from stressed 
mice incorporated 1.34-fold more FAM-VAD-FMK than controls (Figure 31).  
 
Figure 31. Apoptotic potential is increased following stress. 
TG from stressed and nonstressed mice were dissociated into single cell suspensions and 
incubated with FAM-VAD-FMK for 1 h in serum-free media, then labeled with anti-
CD8α and anti-CD45 and analyzed by flow cytometry. Representative histograms show 
extent of FAM-VAD-FMK incorporation in the CD8+ T cell population. Graph shows the 
mean fold-change of the percent FAM-VAD-FMK+ over nonstressed controls.  
4.5.8 Proliferation in vivo is not disrupted following stress.  
Proliferation of CD8+ T cells from stressed TG was impaired in vitro following stress (see Figure 
19A). We measured the rate of proliferation in the TG during the 4 d stress treatment by injecting 
stressed or nonstressed mice with 1 mg BrdU daily (Figure 32). BrdU is a thymidine analogue 
that is incorporated into new synthesized DNA strands, and BrdU incorporation is therefore a 
marker of cells undergoing proliferation (229). After 4 d, the rates of BrdU incorportation were 
remarkably low (<5%), and there were no significant differences between stressed groups and 
controls. Interestingly, there was a significant difference (p = 0.0467, Student’s t test) between 
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the rates of proliferation of gB-specific and gB-nonspecific cells within the stressed mice. This 
data could indicate that the presence of reactivating virus and viral protein expression (Figure 11) 
was inducing a recall response in the virus-specific population. Whether the ratio of virus-
specific to nonspecific cells would change over time given a longer exposure to stress is unclear, 
but after our 4 d stress protocol we did not observe a shift in the ratio (Figure 14B).  
 
Figure 32. Incorporation of BrdU in the TG during stress.  
Latently infected mice were treated with 1 mg BrdU i.p. daily for 4 d during the stress 
protocol. 34 d p.i. mice were sacrificed and BrdU incorporation was measured by flow 
cytometry in CD8α+ cells gated on CD45+ cells. Differences between stressed (n = 4) and 
nonstressed (n = 4) groups were nonsignificant. Among the stressed group, the difference 
in BrdU incorporation between the gB-specific and gB-nonspecific was significant (p = 
0.0302, Student’s paired t test).  
4.5.9 Potential regulators of the stress effect 
Combined, the above data describe a pervasive stress-induced compromise in CD8+ T cell 
function. TG-resident CD8+ T cell number in stressed mice is reduced, and the cells that remain 
have a greater apoptotic potential.  The cells are also impaired in their abilities to proliferate in 
response to antigen and to synthesize cytokines and degranulate upon physiologic stimulation. 
Expression of several surface receptors has been correlated with T cell dysfunction. CD8+ T cell 
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exhaustion during chronic viral infection is associated with increased PD-1 expression, and 
blocking PD-1/PD-L1 interactions restores function in exhausted T cells from chronically 
infected mice (165). Expression of the heteodimer CD94-NKG2A is associated with reduced 
cytotoxicity and blocking the interaction of CD94-NKG2A with its ligand can restore cytotoxic 
ability (148,237). We examined the surface expression of PD-1 and NKG2A on the CD8+ T cells 
from stressed mice. Although we did note stark differential expression among gB-specific and 
gB-nonspecific cells (Figure 33), potentially signifying a differential mechanism for regulating 
the gB-nonspecific cell population in vivo, we did not observe significant differences in the 
expression of either of these receptors due to stress (Figure 34). 
 
Figure 33. Differential expression of PD-1 and NKG2A. 
TG were excised from stressed (closed squares, n = 8) or nonstressed (open squares, n = 
7) mice and labeled with anti-CD45, anti-CD8α, gB498-505/H-2Kb tetramer, anti-PD-1, and 
anti-NKG2A, and analyzed by flow cytometry. (A) The percentage of CD8+ T cells that 
expressed the PD-1 molecule. (B) The percentage of CD8+ T cells that expressed the 
NKG2A molecule. ns, nonsignificant, Student’s t test.  
 
CTLA-4 expression, associated with impaired T cell responses, was also unchanged 
(Figure 34A). Diminished function could also be associated with reduced expression of 
activating receptors such as NKG2D. Roughly half of the CD8+ T cell population expressed 
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NKG2D (Figure 34C), but we did not examine whether there was differential distribution of 
NKG2D or CTLA-4 between the gB-specific and gB-nonspecific populations.  
 
Figure 34. Expression of regulatory receptors on CD8+ T cells in the TG after stress.  
TG-resident CD8+ T cells from stressed (n = 8) and nonstressed (n = 8) mice were 
assayed for cell surface expression of CTLA-4 (A), PD-1 (B), NKG2D (C), or NKG2A 
(D) by flow cytometry. Representative dotplots show the CD45+ population. Numbers in 
the top right quadrant are percent of CD8+ T cells that are positive for the given 
molecule. Graphs on the right are values pooled from 2-4 experiments. ns, not significant, 
Student’s t test.  
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We also examined the spleens of stressed mice, observing a significant decrease in CD8+ 
and CD4+ T cell numbers in stressed spleens (data not shown). To further investigate the 
splenocyte populations, we examined the susceptibility to IL-2 and IL-15 by measuring the 
surface expression of components of their receptors. IL-2 and IL-15 belong to the γc receptor 
family and share two out of 3 receptor components: the IL-2R/IL-15R β chain (CD122) and the 
common γ chain (CD132) (159). IL-2 binds the CD122/CD132 complex with low affinity, but 
when IL-2Rα (CD25) is present, IL-2 binds the tripartite receptor with high affinity. IL-15 binds 
the IL-15Rα subunit and can be presented to the CD122/CD132 receptor complex in trans 
(157,238), thus IL-15Rα is dispensible on the T cell surface (158). Therefore we investigated 
whether stress affected the surface expression of CD25, the IL-2Rα chain, and CD122, the IL-
2R/IL-15R β chain (Figure 35) on CD8+ and CD4+ T cells in the spleen. We did not observe any 
overt differences between stressed and nonstressed spleens in the expression of CD25, CD122, 
or CD132 on CD8+ or CD4+ T cells. Thus, sensitivity of the remaining T cell populations to IL-
2, and, perhaps, IL-15 as well, remains unaffected following stress.  
 
Figure 35. Surface receptor expression on splenocytes after stress. 
Spleens were removed from stressed (n = 4) or nonstressed (n = 3) mice, labeled with 
antibodies to CD45, CD4, CD8, CD25, CD122, and CD132, then analyzed by flow 
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cytometry. Representative dotplots show the expression of CD122 (A) and CD25 (B) and 
CD132 on CD8+ T cells (top row) and CD4+ T cells (bottom row). Numbers in the top 
right quadrant indicate the percentage of the population that is double-positive for 
expression of CD132 and the receptor of interest.  
4.6 ROLE OF CORTICOSTERONE IN STRESS RESPONSE 
4.6.1 Direct corticosterone treatment dramatically reduces CD8+ and CD4+ T cells in the 
TG 
The main effector molecules of the stress response are glucocorticoids. In mice, the major 
glucocorticoid is corticosterone. In order to recapitulate the effects of stress, mice were treated 
with 400 µg/ml corticosterone in their drinking water for 4 consecutive days during latency. This 
dose correlates with a greater-than-mild stress response, and is similar to doses used in 
corticosterone control-release implants (239,240). Figure 36 shows the results in CD8+ T cells 
and CD4+ T cells. For both cell types, corticosterone treatment dramatically reduced the number 
of cells, up to 90% for CD8s.  
 
Figure 36. Reduction in T cell numbers following direct corticosterone treatment. 
 83 
Mice were treated with 400 µg/ml corticosterone in their drinking water for 4 d during 
latency. TG from corticsosterone treated or nontreated mice were excised and labeled 
with anti-CD45, anti-CD4, and anti-CD8α and analyzed by flow cytometry. Nontreated 
(CD8, n = 4, CD4, n =10), Treated (CD8, n = 7, CD4, n = 13). * p = 0.0121, ** p = 
0.0039, Student’s t test.  
 
4.6.2 Loss of CD8+ T cells is due in part to apoptosis 
Glucocorticoids are well-known mediators of apoptosis in T cells (181). The 90% reduction in 
CD8+ T cell number following corticosterone treatment could be due to apoptosis of the TG-
resident T cell population. TG cells were labeled with Annexin-V, a molecule that binds 
phosphatidylserine on the cell surface (241). Phosphatidylserine is a lipid molecule that is 
normally only found in the inner leaflet of the plasma membrane; expression of 
phosphatidylserine on the outside of the plasma membrane is an early marker of apoptosis. TG 
whole mounts from corticosterone treated or nontreated mice were stained with anti-CD8α and 
Annexin-V and analyzed by confocal microscopy (Figure 37). While nearly all CD8+ T cells in 
the corticosterone-treated TG costained with Annexin-V, indicating they were apoptotic, no 
CD8+ T cells in nontreated TG costained with Annexin-V.  
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 Figure 37. Corticosterone-mediated apoptosis of CD8+ T cells in the TG. 
Latently infected corticosterone treated or nontreated mice were perfused with 1% PFA. 
TG were excised and labeled with anti-CD8α (red) and Annexin-V (green), then 
analyzed by confocal microscopy. 
4.6.3 Direct corticosterone treatment enriches for activated cells. 
We examined the activation status of the remaining CD8+ and CD4+ T cells following 
corticosterone treatment. In both populations, the percentage of cells that were positive for the 
early activation marker CD69 was significantly increased (Figure 38). Whether corticosterone 
treatment leads to T cell activation, or whether CD69 expression designates cells that are more 
resistant to the apoptotic effects of stress is currently unknown. In latently infected TG, most of 
the cells are CD69+, so the significance of our observed increase in CD69 expression is also 
unknown. A combination of corticosterone directly or indirectly activating cells, and activation 
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subsequently promoting the survival of these cells is most likely the explanation for these 
observations. It should be noted, though, that the absolute numbers of CD69+ cells is still 
significantly lower in corticosterone treated mice versus controls, as there are much fewer cells 
total (see Figure 36).  
 
Figure 38. Corticosterone treatment enriches for activated T cells.  
TG from corticosterone treated or nontreated mice were excised and labeled with anti-
CD45, anti-CD8α, anti-CD4, and anti-CD69 and analyzed by flow cytometry. Graph 
shows the percentage of CD8+ or CD4+ T cells that express CD69. Nontreated, n = 9, 
Corticosterone treated, n = 13. ** p = .0010, *** p < 0.0001, Student’s t test.  
 
4.6.4 Frequency of virus-specific T cells is unchanged following corticosterone treatment.  
The retention of activated cells did not translate to a selective retention of virus-specific cells 
(Figure 39A). Given that most of the T cells are already activated in the latently infected TG, this 
result is not altogether surprising. One interesting phenomenon occurred when mice were treated 
with corticosterone longer than 4 d. Following a 10 d corticosterone treatment, the numbers of 
CD8+ T cell in the TG were similar to that seen after only 4 d of treatment (compare Figure 39B 
with Figure 36). Additionally, the percentage of gB498-505-specific CD8+ T cells in the TG after 
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10 d of treatment was similar to nontreated controls (Figure 39C). These data could be explained 
by at least two hypotheses: i) that approximately 10% of the CD8+ T cells in the latently infected 
TG are resistant to corticosterone, or ii) the TG is replenished continuously by approximately 
10% of the total TG cell pool. The former hypothesis implies that glucocorticoid resistance is 
evenly distributed between the virus-specific and nonspecific cells. The latter hypothesis implies 
that the infiltration of cells into the ganglia is preferential for virus-specific cells, since the even 
distribution of virus-specific and nonspecific cells that results derives from a much lower 
frequency of virus-specific cells in the circulation (data not shown).   
 
Figure 39. gB-specificity following corticosterone treatment. 
TG from corticosterone treated or nontreated mice were excised and labeled with anti-
CD45, anti-CD8α, and gB498-505/H-2Kb tetramers and analyzed by flow cytometry. (A) 
The percentage of CD8+ T cells that specific for gB498-505 after 4 d of corticosterone 
treatment. Nontreated, n = 4, corticosterone treated, n = 7. (B) The absolute number of 
CD45+ CD8+ T cells per TG after 10 d of corticosterone treatment. Nontreated, n = 2, 
corticosterone  treated, n = 4. * p = 0.0108. Student’s t test. (C) The percentage of CD8+ 
T cells that specific for gB498-505 after 10 d of corticosterone treatment. Nontreated, n =2, 
corticosterone treated, n = 4.  
4.6.5 Direct corticosterone treatment does not dysregulate granzyme B expression. 
Surprisingly, the selective retention of activated cells after 4 d of treatment did not correlate with 
an increase in intracellular granzyme B, as observed following stress (see Figure 26). The virus-
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specific CD8+ T cell population did not increase the MFI for intracellular granzyme B (Figure 
40). Although glucocorticoids have been shown to affect cytotoxicity in some studies (206,242), 
in others cytotoxicity is affected by catecholamines (203,243). Remarkably, in the gB-
nonspecific population granzyme B expression was actually decreased 45% (Figure 41). The 
significance of this finding is currently unknown.  
 
Figure 40. Direct corticosterone treatment does not affect intracellular granzyme B. 
TG were excised from latently infected corticosterone treated (CORT, n = 12) or 
nontreated (n = 12) mice were labeled with anti-CD8α, anti-CD45, and gB498-505/H-2Kb 
tetramers. Cells were then permeabilized and measured for intracellular granzyme B by 
flow cytometry. Graph depicts the relative MFI (± SEM) of granzyme B antibody in the 
CD8+tetramer+ population. ns, not significant, Student’s t test.  
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 Figure 41. Corticosterone treatment decreases intracellular granzyme B in the gB-
nonspecific population.  
 
TG were excised from latently infected corticosterone treated (CORT, n = 12) or 
nontreated (n = 12) mice were labeled with anti-CD8α, anti-CD45, and gB498-505/H-2Kb 
tetramers. Cells were then permeabilized and measured for intracellular granzyme B by 
flow cytometry. Graph depicts the relative MFI (± SEM) of granzyme B antibody in the 
CD8+tetramerneg population. * p = 0.0367, Student’s t test.  
4.6.6 IFN-γ synthesis is not affected following corticosterone treatment 
As we observed following stress treatment, direct corticosterone treatment had no overt effect on 
the ability of CD8+ T cells to produce IFN-γ in response to optimal stimulation. Figure 42 shows 
the percentage of CD8+ T cells that respond to stimulation with IFN-γ is equivalent in 
corticosterone treated and nontreated mice. In addition, the amount of IFN-γ produced per cell is 
similar between the groups. These data suggest that although there is a nearly 90% reduction in 
the absolute number of CD8+ T cells capable of producing IFN-γ, the actual IFN-γ synthesis 
machinery is not disrupted by glucocorticoid treatment.  
 89 
 Figure 42. The IFN-γ response following direct corticosterone treatment. 
TG from corticosterone treated or nontreated mice were excised, incubated for 6 h with 
10-12M gB498-505 peptide pulsed B6WT3 fibroblasts in the presence of GolgiPlug™. Cell 
suspensions were then labeled with anti-CD8α and anti-CD45, permeabilized, stained for 
intracellular IFN-γ and analyzed by flow cytometry. Representative dotplots on the left 
gated on CD45+ T cells. Numbers in top right quadrants indicate percentage of CD8+ T 
cells positive for IFN-γ expression. Graph on the right is relative MFI of IFN-γ 
expression pooled from 2 experiments. Nontreated, n = 7, Treated, n = 8. ns, not 
significant, Student’s t test.  
 
The cytokine response of corticosterone treated CD8+ T cells was not tested at 
suboptimal concentrations of peptide, so the possibility exists that glucocorticoids are 
responsible for the compromise in the cytokine response at low densities of antigen.  
Adrenalectomy, which eliminates glucocorticoids, has been shown to restore stress-induced 
compromises in the production of IL-6 and IFN-γ (220). 
4.6.7 Degranulation is not affected following corticosterone treatment.  
As depicted above, direct corticosterone treatment did not affect intracellular granzyme B 
retention in the gB-specific CD8+ T cell pool (Figure 40). With stress treatment, the higher 
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granzyme B levels coincided with a reduced ability to degranulate at low epitope densities. 
Optimal stimulation restored the ability of the CD8+ T cells to degranulate (Figure 25B), 
although proliferation was still reduced (Figure 19A and B). Given the gB-specific population 
was not compromised in their levels of intracellular granzyme B following corticosterone 
treatment, we would not hypothesize that degranulation capacity per cell would be impaired in 
corticosterone treated mice. Accordingly, under optimal stimulation conditions, the percentage of 
CD8+ T cells that degranulated and the amount of surface CD107a expression per cell did not 
differ between treated or control groups in a 6 h assay (Figure 43). We did not measure the 
degranulation response at suboptimal epitope densities.  
 
Figure 43. CD107a expression following direct corticosterone treatment.  
TG from corticosterone treated or nontreated mice were excised, incubated for 6 h with 
10-12M gB498-505 peptide pulsed B6WT3 fibroblasts in the presence of GolgiPlug™ and 
anti-CD107a. Cell suspensions were then labeled with anti-CD8α and anti-CD45, and 
analyzed by flow cytometry. Representative dotplots on the left gated on CD45+ T cells. 
Numbers in top right quadrants indicate percentage of CD8+ T cells positive for CD107a 
expression. Graph on the right is relative MFI of CD107a expression pooled from 2 
experiments. Nontreated, n = 7, Treated, n = 8. ns, not significant, Student’s t test.  
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4.6.8 Reactivation is not affected following corticosterone treatment. 
Glucocorticoid treatment protocols have been shown to induce α-herpesvirus reactivation from 
latency in animal models and in culture (244-249). Restraint stress and in vivo depletion of CD8+ 
T cells during latency each resulted in a significant increase in viral genome copies per TG. 
Given that corticosterone treatment drastically reduces the absolute number of IFN-γ producing 
cells, we anticipated that direct corticosterone treatment would also result in reactivation of latent 
HSV-1. To our surprise, glucocorticoid treatment did not result in an increase in viral DNA 
levels in the TG (Figure 44A). This data does fit with other published studies in which 
glucocorticoid treatment did not induce, or only mildly induced, viral reactivation (250,251). It 
would seem, therefore, that the uncompromised ability of the remaining CD8+ T cells to 
degranulate is a major determinant in the prevention of HSV-1 reactivation from latency. Of 
course, we did not directly measure the ability of corticosterone treated CD8+ T cells to produce 
cytokines in vivo or in response to neurons in culture, so, if the treated cells are not impaired in 
their cytokine production at low antigen concentrations, that, too, could potentially add to the 
success of the remaining CD8+ T cells to protect from reactivation in vivo.  
To asses the effect of corticosterone treatment on the abilities of CD8+ T cells to prevent 
reactivation in culture, exogenous gB-specific T cells were added to T cell-depleted cultures 
from latently infected, nontreated mice and then treated with 10-6 M corticosterone in vitro 
(Figure 44B). Reactivation of latent virus was undetectable in treated cultures for 6 d, and only in 
3% of wells at 7 d in culture. This suggests that the ability of the exogenous CD8+ T cells to 
prevent reactivation was not compromised by direct corticosterone treatment in culture.  
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The lack of glucocorticoid-induced reactivation could also be attributable to a biphasic 
effect in which glucocorticoids disrupt T cell immunity but also act directly on the neuron to 
block viral DNA replication. To assess whether reactivation in neurons themselves could be 
inhibited by direct corticosterone treatment, TG were depleted of endogenous T cells and 
cultured with or without 10-6 M corticosterone (Figure 44C). Without allogeneic virus-specific 
CD8+ T cells, ex vivo TG cultures reproducibly reactivate (64,65). Direct corticosterone 
treatment in culture did not inhibit the rate of reactivation in TG cultures through 9 d post 
explant.  
 
Figure 44. Reactivation following corticosterone treatment in vivo or in vitro. 
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(A) DNA was isolated from TG from mice that were either nontreated or treated with 
corticosterone for 4 or 10 d. (B) HSV-1 pgB-EGFP-infected TG were depleted of 
endogenous CD8+ T cells by Dynabead™ negative selection. 106 exogenous gB-specific 
CD8+ T cells were then added to the cultures that were either treated in vitro with 10-6M 
corticosterone or nontreated, and reactivation was measured by examining cultures daily 
for spread of fluorescence. (C) HSV-1 pgB-EGFP-infected TG were depleted of 
endogenous CD45+ T cells by Dynabead™ negative selection and left nontreated or 
treated with 10-6M corticosterone in vitro. Reactivation was measured by examining 
cultures daily for spread of fluorescence.  
4.7 BLOCKING β-ADRENERGIC RECEPTORS CAN INHIBIT THE STRESS-
INDUCED GRANZYME B INCREASE 
As described above, restraint stress impairs lytic granule release and cytotoxicity, evidenced by 
an increase in granzyme B. Surprisingly, direct corticosterone treatment did not result in a 
similar increase in intracellular granzyme B. These data suggest that the stress-induced 
compromise in lytic granule release may be a glucocorticoid-independent phenomenon. We 
sought to address the role of the SNS in our model by treating stressed mice with nadolol, a β-
adrenergic receptor antagonist. In two out of 3 experiments, nadolol treatment reduced or 
blocked the stress-induced increase in the amount of intracellular granzyme B (Figure 45). These 
data are in accordance with previous studies in which nadolol treatment restored the stress-
induced impairment in CD8+ T cell cytotoxic ability (203). In addition to using nadolol to restore 
cytotoxicity, Dobbs, et al, treated stressed mice with the glucocorticoid receptor antagonist 
RU486, but did not observe a restoration of cytotoxic ability (203). Thus, glucocorticoid 
signaling was not required for the stress-induced defect in cytotoxicity. Indeed, in our hands, 
direct corticosterone treatment does not promote the accumulation of intracellular granzyme B, 
so most likely, cytotoxicity is governed by catecholamines and not glucocorticoids.  
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 Figure 45. Nadolol treatment during stress can reverse the increase in granzyme B. 
Mice were treated with nadolol (5 mg/kg in PBS/0.2% EtOH) i.p. beginning 1 d prior to 
stress and continuing daily. At 34 d p.i., TG were excised, permeabilized, and labeled 
with antibodies to CD45, CD8, and intracellular granzyme B, then analyzed by flow 
cytometry. Relative MFI (± SEM) is shown for three separate experiments. Nonstressed 
(hatched bars, n = 3-4/group/experiment), stressed (solid bars, n = 4/group/experiment).  
 
Interestingly, our nadolol treatment protocol of daily i.p. injections appears itself to 
increase serum levels of corticosterone, in all 3 experiments (compare serum corticosterone 
levels for nonstressed mice in Figure 10 and Figure 46). Here, we see that the serum 
corticosterone levels of the nonstressed mice has either matched, or surpassed, the serum 
corticosterone levels in the stressed mice. These data add to the evidence that glucocorticoids are 
not responsible for the stress-induced increase in granzyme B, as even in the face of elevated 
serum glucocorticoids, nonstressed mice have consistently less intracellular granzyme B than 
stressed mice.  
It has yet to be determined whether the stress-induced increase in intracellular granzyme 
B is correlated with reduced T cell cytotoxicity. The newly developed FAM-VAD-FMK 
cytotoxicity assay (Figure 29) will allow us to examine (i) whether stressed CD8+ T cells are 
inhibited in their ability to induce apoptosis in target cells, (ii) if the 6 h stimulation causes a 
measurable decrease in intracellular granzyme B in nonstressed controls, indicative of 
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degranulation, (iii) if the stressed CD8+ T cells are compromised in degranulation, and (iv) if in 
vivo nadolol treatment restores cytotoxicity and degranulation.  
 
Figure 46. Serum corticosterone levels following stress and nadolol treatment.  
Mice were treated with nadolol (5 mg/kg in PBS/0.2% EtOH) i.p. beginning 1 d prior to 
stress and continuing daily. At 34 d p.i., mice were sacrificed and serum corticosterone 
levels were determined by standard radioimmunoassay. Nonstressed (hatched bars, n = 3-
4/group/experiment), stressed (solid bars, n = 3-4/group/experiment). CORT, 
corticosterone.  
4.8 THE EFFECTS ON T CELL MEMORY BY STRESS OR CORTICOSTERONE 
TREATMENT DURING PRIMARY INFECTION 
Given the changes in immunity seen following stress or glucocorticoid treatment, stress during 
an acute immune response could have severe complications on the development and quality of 
the immunologic memory response.  
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4.8.1 Stress reduces CD8+ T cell number in the TG 
 
Figure 47. Effects of stress during primary infection. 
HSV-1 infected mice were stressed 4-8 d p.i. At 8 d p.i., TG were excised, labeled with 
anti-CD45, anti-CD8α, anti-CD4, and gB498-505/H-2Kb tetramers, and analyzed by flow 
cytometry. The numbers of nonstressed (n = 10-14) and stressed (n = 12-16) CD8+, 
CD8+gB498-505-specific, and CD4+ T cells is shown. ** p < 0.004, *** p < 0.0001, 
Student’s t test.  
 
Restraint stress beginning 4 d p.i. and continuing nightly for 4 consecutive nights results in an 
approximately 57% reduction in CD8+ T cell number and virus-specific CD8+ T cell number, and 
an approximately 40% reduction in CD4+ T cell number in the TG (Figure 47). As both CD8+ 
and gB-specific CD8+ T cell numbers were reduced a similar percentage, the overall percentage 
of CD8+ T cells that were specific for HSV-1 did not change following restraint stress. 
Corticosterone treatment during acute infection also resulted in a dramatic decrease in CD8+ and 
CD4+ T cell number in the TG. Somewhat surprising, however, was the observation that gB-
specific CD8+ T cells were selectively retained in the TG (Figure 48), suggesting early in 
infection gB-specific T cells are more resistant to glucocorticoids than the overall CD8+ T cell 
population.  
 97 
 Figure 48. T cell number in the TG following early corticosterone treatment.  
Mice were treated with 400 µg/ml corticosterone in their drinking water from 4-8 d p.i. 
At 8 d p.i., TG were excised, labeled with anti-CD45, anti-CD8α, anti-CD4, and gB498-
505/H-2Kb tetramers, and analyzed by flow cytometry. The numbers of nonstressed (n = 3) 
and stressed (n = 4) CD8+ and CD4+ T cells are shown in black on the left axis. In green, 
the percentage of CD8+ T cells that are specific for gB498-505 is shown on the right axis. * 
p = 0.0395, ** p = 0.0070, *** p < 0.0001, Student’s t test.  
 
When mice were treated with corticosterone during latency, activated T cells were 
selectively retained in the TG (Figure 38). A similar phenomenon was observed when mice were 
corticosterone treated during acute infection (Figure 49). Together, these data provide evidence 
that CD69 expression correlates with glucocorticoid resistance. Interestingly, the percentage of 
CD69+ T cells did not increase following restraint stress (data not shown). There are two 
potential hypotheses that may address this issue: (i) the glucocorticoid-mediated effects of 
restraint are not severe enough (compare serum corticosterone levels between stressed and 
corticosterone treated groups in Figure 10) to reduce T cell numbers enough to where activation-
mediated cell survival is detectable, and (ii) stress-induced effects that are glucocorticoid-
independent actually intervene in the pro-survival capabilities of activated T cells in the TG. 
These hypotheses are not mutually exclusive and are readily testable.  
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 Figure 49. Expression of CD69 following early corticosterone treatment.  
Mice were treated with 400 µg/ml corticosterone in their drinking water from 4-8 d p.i. 
At 8 d p.i., TG were excised, labeled with anti-CD45, anti-CD8α, anti-CD4, and anti-
CD69, and analyzed by flow cytometry. The percentage of nonstressed (n = 3) and 
stressed (n = 4) CD8+ and CD4+ T that are CD69+ is shown. * p = 0.091, ** p = 0.0068, 
Student’s t test.  
4.8.2 Control of viral infection in the face of stress during acute infection.  
In our model, virus is reproducibly cleared from the eye by 8-10 d p.i. (252). Innate immune 
mechanisms are most important for the initial clearance of virus and for driving the virus to 
latency in the TG. The stress protocol was initiated 4 d p.i. and may have affected the ability of 
the innate immune response to adequately clear the virus. In addition, fewer T cells either enter, 
or are retained, in the TG at the peak of the response in the face of stress or corticosterone 
treatment (Figure 47 and Figure 48). We measured viral clearance in the eyes of mice during the 
stress treatment (Figure 50). By 8 d post infection, only 1 out of 8 nonstressed mice had 
detectable virus in the tear film but 4 out of 8 stressed mice had detectable virus (data not 
shown). The virus titer at 8 d was 34-fold higher in stressed mice (Figure 50A). In the TG, stress 
during acute infection had no effect on viral genome copy number (Figure 50B). Initial clearance 
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of virus is mediated mostly by the innate immune system, and therefore, beginning stress 4 d 
post infection may be too late in the infectious cycle in which to observe a change in the 
establish of viral latency. Interestingly, corticosterone treatment induced a nearly 4-fold increase 
in viral genome copies (Figure 50B). These data suggest that early in infection, the number of 
CD8+ T cells correlates better with viral load than during latency. Conversely, direct 
corticosterone treatment could affect innate immune components, important in driving the virus 
to latency, more so than restraint, due to higher serum corticosterone levels.  
 
Figure 50. Viral clearance and control after early treatment. 
Mice were stressed or corticosterone treated 4-8 d p.i. (A) Daily eye swabs were taken 
and plaque assays were performed on Vero cell monolayers from nonstressed (hatched 
bars, n = 2-8) or stressed (solid bars, n = 2-8) mice daily during the stress treatment. At 7 
d p.i. no virus was detected. (B) At 8 d p.i., TG were excised from nonstressed (n = 7), 
stressed (n = 8), nontreated (n = 3), or corticosterone treated (n = 4) mice, DNA was 
isolated and analyzed by real-time PCR for the HSV-1 gH gene.  * p = 0.0456, Student’s 
t test.  
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4.8.3 Formation of CD8+ T cell memory following stress 
We examined the population of CD127+ memory T cell precursors in the TG at 8 d p.i. 
Expression of CD127 (IL-7Rα) marks a population of T cells during the effector phase that are 
potentially destined to become memory T cells, although expression of CD127 alone is not 
sufficient to become a memory cell (125,126). Following stress, there was a significant 54% 
reduction in gB498-505 specific CD8+CD127+ T cells, but surprisingly, there was no change in the 
gB-nonspecific CD127+ population (Figure 51A). Because the total T cell pool in the TG was 
reduced (Figure 47), but the number of gB-nonspecific CD127+ cells was unchanged, there was a 
2.6-fold increase in the percentage of gB-nonspecific CD127+ cells.  
 
Figure 51. CD8+ memory precursors following stress, 8 d p.i.. 
Mice were stressed 4-8 d p.i. (n = 4) or nonstressed (n = 4) and sacrificed 8 d p.i. TG 
were then excised and labeled with antibodies to CD45, CD8, CD127 (IL-7Rα), and 
gB498-505/H-2Kb tetramers. (A) The number of CD127+ cells in the gB-specific or gB-
nonspecific populations. (B) The percentage of CD127+ cells in the gB-specific or gB-
nonspecific populations. * p = 0.0269, ** p = 0.0066, ns, not significant, Student’s t test.  
  
We next examined CD127 expression on CD8+ T cells at a point early in latency (14 d 
p.i.) to measure if the stress-induced changes at 8 d p.i. influenced the memory T cell pool 
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(Figure 52). Surprisingly, the abundance of gB-nonspecific CD127+ T cells at 8 d p.i. in stressed 
mice (2.7-fold more than gB-specific CD127+ cells, see Figure 51A) was corrected by 14 d p.i. 
Comparing Figures 51A and 52C, the most interesting observation is that the absolute number of 
stressed, gB-nonspecific CD127+ cells does not change from 8 to 14 d p.i., whereas the absolute 
number of stressed, gB-specific CD127+ cells significantly increases (p = 0.0045). These data 
suggest that between 8 and 14 d p.i. gB-specific CD127+ cells infiltrate into, or proliferate 
within, the TG at a much faster rate than gB-nonspecific memory precursors. Additionally, stress 
during the expansion phase does not appear to affect this increase.  
 
Figure 52. Phenotype of CD8+ T cells 14 d p.i., after early stress treatment. 
Mice were stressed 4-8 d p.i. (n = 3) or nonstressed (n = 4) and sacrificed 14 d p.i. TG 
were then excised and labeled with antibodies to CD45, CD8, CD127 (IL-7Rα), and 
gB498-505/H-2Kb tetramers. (A) The number of CD8+ cells in TG. (B) The percentage of 
CD8+ T cells that are gB-specific. (C) The number of CD127+ cells in the gB-specific or 
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gB-nonspecific populations. (D) The percentage of CD127+ cells in the gB-specific or 
gB-nonspecific populations. ns, not significant, Student’s t test.  
 
The absolute number of stressed CD8+ T cells is not significantly different from 
nonstressed controls at 14 d p.i. (Figure 52A). However, the number of cells at 14 d p.i. is similar 
to the number of stressed CD8+ T cells 8 d p.i., the peak of T cell infiltrate. Whether this number 
of CD8+ T cells remained constant between days 8 and 14, or if CD8+ T cell number increases 
and then contracts post-stress, was not investigated in this study.  
Memory cells undergo a basal level homeostatic proliferation that is independent of 
cognate antigen (123,156). Chronic infections, on the other hand, can lead to Ag-dependence or 
depletion of the memory cell pool (162,163). In latently infected TG, memory T cell numbers are 
maintained in the absence of IL-15 signals, but in the uninfected lung, the virus-specific memory 
cell pool is dependent on IL-15-mediated homeostatic signals (67). Whether the IL-15-
independent memory cells require Ag to maintain their numbers is currently unknown. To 
investigate whether stress during expansion affects the ability of the memory response maintain 
stable numbers over time in the TG, we measured the amount of T cells in latently infected TG at 
34 d p.i. It should be noted that although 14 d p.i. is an early time point in which the virus is 
already latent, it is still in the midst of the contraction phase, and thus T cell numbers are greater 
at 14 d than at 34 d p.i. We were unable to detect significant differences in the numbers of CD8+ 
or CD4+ T cells in the TG at 34 d p.i., regardless of whether the mice were stressed early (Figure 
53A). Accordingly, the percentages of CD8+ T cells that were gB-specific or activated (CD69+) 
was unchanged (Figure 53B). These data suggest that the T cell memory pool is established 
properly, at least numerically, despite the deficiency in cell number at the peak of expansion due 
to the early stress treatment.  
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 Figure 53. T cell phenotype at 34 d p.i., after early stress treatment.  
TG were excised at 34 d p.i. from mice that were either nonstressed (n = 2-18) or stressed 
4-8 d p.i. (n = 8). TG were stained with antibodies to CD45, CD8, CD4, CD69, and 
gB498-505/H-2Kb tetramers, and analyzed by flow cytometry. (A)  The number (± SEM) of 
CD8+ and CD4+ T cells in the TG at 34 d p.i. (B) The percentage (± SEM) of CD8+ T 
cells that were gB498-505-specific or CD69+ is shown. ns, not significant, Student’s t test.  
4.8.4  Memory function following stress.  
The abilities of memory CD8+ T cells in the TG to synthesize IFN-γ and degranulate were 
examined. Unlike previous studies (217,220,221,223), no functional deficiencies in the memory 
CD8+ T cells within the TG were observed following stimulation with an optimum dose of gB498-
505 peptide (Figure 54) following stress during the primary infection. The discrepancy between 
our results and previous results could be due to several reasons, including differences between 
TG-resident cells and cells of peripheral immune organs, differences in the route of HSV-1 
infection, and differences in the timing of the restraint sessions. The function of these memory 
CD8+ T cells to respond at suboptimal doses of stimulation was not tested. Thus, our data 
presents a situation in which stress during the primary infection dysregulates the expansion of the 
CD8+ T cell response, but does not seem to affect the establishment or functionality of the 
memory T cell pool.  
 104 
 Figure 54. Memory T cell function following stress during the primary infection. 
TG were excised at 34 d p.i. from mice that were either nonstressed (n = 4) or stressed 4-
8 d p.i. (n = 4). TG were stimulated for 6 h with gB498-505 peptide-pulsed fibroblasts in 
the presence of GolgiPlug and anti-CD107a, then stained with antibodies to CD45, CD8, 
and intracellular IFN-γ, and analyzed by flow cytometry. (A) Representative dotplots 
show the production of IFN-γ (left column) or expression of CD107a (right column) on 
CD45+ cells.  Numbers in the top right quadrant indicate the percentage of CD8+ T cells 
that express the given marker. (B) The MFI of IFN-γ (left graph) or CD107a (right graph) 
expression is shown.   
 
One additional measurement of the memory T cell response in the TG following stress 
during the primary infection is whether the T cells are more or less susceptible to the effects of 
stress during latency. If stress early in infection sensitizes the memory pool to stressful stimuli 
during latency, then one explanation for why some individuals reactivate more often is that they 
could have been stressed when they were first infected. We measured the number of CD8+ T 
cells in the TG at 34 d p.i., after stress 4-8 d p.i., 30-34 d p.i., or both (Figure 55A). Stress during 
both primary infection and latency did not result in an additional significant decrease in CD8+ T 
cell numbers in the TG versus single stress treatment early in infection or single stress treatment 
during latency (as measured by one-way ANOVA). Student’s t tests reveal significantly different 
cell numbers between mice stressed in both sessions and nonstressed mice (p = 0.0495), but no 
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significant differences in cell number compared to mice stressed early or late only. A repetition 
of this experiment to increase the n values of the stressed early and stressed both groups may 
provide enough power to observe significant differences. However, since T cell number does not 
seem to be the clearest indicator of CD8+ T cell-mediated protection (compare the numbers of 
CD8+ T cells following stress and the resulting viral genome copy number versus the numbers of 
cells and HSV-1 copy number following direct corticosterone treatment), we also examined the 
levels of HSV-1 genomes in the TG (Figure 55B). Although there was a general trend toward 
more genome copies after stress both early and late, there were no significant differences among 
the groups. More thorough investigation is certainly required to examine whether stress during 
the primary infection sensitizes the memory CD8+ T cells to stress-mediated effects during 
latency.  
 
Figure 55. Effects of multiple stress treatments. 
TG were excised at 34 d p.i. from mice that were either nonstressed (n = 16), stressed 4-8 
d p.i. (stressed early, n = 8), stressed 30-34 d p.i. (stressed late, n = 27), or stressed 4-8 d 
p.i. and 30-34 d p.i. (stressed both, n = 4). (A) One TG equivalent per mouse was labeled 
with anti-CD45 and anti-CD8α, analyzed by flow cytometry, and CD8+ T cells in the TG 
were enumerated. (B) DNA was isolated from one TG equivalent per mouse and viral 
genome copy number was measured by real-time PCR for the HSV-1 gH gene.  
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5.0  DISCUSSION 
5.1 STRESS-INDUCED CD8+ T CELL COMPROMISE PROMOTES 
REACTIVATION 
The association of stress and HSV-1 reactivation from latency is well established in mice, but a 
specific mechanism by which stress facilitates HSV-1 reactivation has not been elucidated. The 
potential involvement of CD8+ T cells in maintaining HSV-1 in a latent state has only recently 
been appreciated (62,64,65,68,253). CD8+ T cells surround HSV-1 infected neurons in latently 
infected TG of both mice and humans (65,114), maintain an activation phenotype (65), form an 
apparent immunologic synapse with neurons (65), and can block HSV-1 reactivation from 
latency in ex vivo cultures of latently infected TG (64,65). These findings are consistent with a 
dynamic form of latency in which HSV-specific CD8+ T cells constantly monitor and repress 
viral reactivation in at least a portion of latently infected neurons. This study provides the first 
direct evidence that constant monitoring by CD8+ T cells is required to uniformly maintain HSV-
1 latency. The rapid rise in HSV-1 genome copy number following CD8+ T cell depletion 
(greater than 2-fold increase in genome copy number within 3 days) demonstrates that some 
latently infected neurons are reactivation competent at any given time, and prevented from 
progressing to full reactivation with virion formation only through the constant vigilance of 
CD8+ T cells.   
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A similar increase in viral DNA was observed in mice that were subjected to restraint 
stress. The increase in viral DNA was apparent by the end of the 4-day stress protocol and 
reached statistical significance by 4 d after stress cessation. Although all stressed TG showed 
elevated viral DNA, the degree of increase varied substantially in individual stressed TG. Only 
one of eight tested TG exhibited replicating HSV-1 directly ex vivo (data not shown). The 
detection of replicating virus in even one stressed TG is highly significant as we and others have 
uniformly failed to detected infectious virions in any latently infected nonstressed TG (38,47). A 
recent study showed only 30% of samples containing 1x105 genome copies were culture positive 
(230). Thus, it is likely that only those stressed TG with the greatest increase in viral DNA 
achieved a necessary threshold for detection in culture. Additionally, the non-uniformity of stress 
induced reactivation could explain our inability to reproducibly detect increased reactivation in 
TG cultures from stressed mice compared to nonstressed controls, even when using sensitive 
recombinant promoter viruses.  
The similar rise in viral genome copy number following CD8+ T cell depletion and 
exposure to restraint stress is consistent with the possibility that stress-induced HSV-1 
reactivation results from a transient compromise in CD8+ T cell surveillance. In support of this 
concept is the observed 30% reduction of CD8+ T cells in stressed TG. The reduced numbers of 
CD8+ T cells might reflect in part the impaired proliferative capacity of CD8+ T cells in stressed 
TG when responding to reactivating virus which would be in agreement with the previous 
observation that restraint stress can impair mitogen-stimulated T cell proliferation (254). We 
demonstrated that the basal rate of proliferation of HSV-specific memory CD8+ T cells in 
latently infected TG is regulated at least in part by antigen stimulation, whereas their 
counterparts in non-infected tissue are maintained by homeostatic proliferation in response to 
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cytokines, including IL-15 (67). Thus, a reduced capacity to proliferate in response to 
reactivating virus would likely result in a gradual reduction of the TG-resident CD8+ T cell pool. 
However it is unlikely that impaired proliferation alone would account for the 30% reduction in 
CD8+ T cell numbers in stressed TG because the rate of turnover of these cells is quite low - less 
than 20% of CD8+ T cells incorporate BrdU during a one-week treatment period (67). Moreover, 
we demonstrated a higher rate of apoptosis in CD8+ T cells in stressed as compared to those in 
non-stressed TG. Thus proliferative impairment and elevated apoptosis likely contribute to the 
reduced CD8+ T cell pool in stressed TG.  
In addition to the reduced numbers of HSV-specific CD8+ T cells in stressed TG is the 
observed functional impairment of the surviving cells. When tested in vivo or directly ex vivo 
less than 2% of CD8+ T cells in stressed or nonstressed TG exhibited detectable IFN-γ 
production. However, when nonstressed TG were incubated for 72 h approximately 10% of the 
endogenous CD8+ T cells were stimulated to produce IFN-γ. Our studies have established that 
TG-resident CD8+ T cells in part through IFN-γ production prevent HSV-1 reactivation from 
latency that is first apparent by 72 h of culture. Since only neurons harbor latent virus in latently 
infected ganglia (64,255-257), and CD8+ T cells prevent full HSV-1 reactivation with virion 
formation in TG cultures (64,65), we conclude that TG-resident HSV-specific CD8+ T cells 
produce IFN-γ in ex vivo TG cultures in response to reactivating HSV-1 in sensory neurons. 
Therefore, it is important to note that TG-resident CD8+ T cells in stressed TG did not 
significantly increase IFN-γ production during a 72 h ex vivo TG culture. The stressed TG 
contained a similar frequency of HSV-specific CD8+ T cells, and the addition of an optimal 
stimulatory dose of gB498-505 peptide induced a similar frequency of IFN-γ producing CD8+ T 
cells in stressed and nonstressed TG cultures, and the kinetics of IFN-γ production was similar. 
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Together these findings suggest that the stress-induced functional impairment of CD8+ T cells is 
not absolute, but rather appears to specifically inhibit the capacity of HSV-specific CD8+ T cells 
to respond to reactivating HSV-1 in sensory neurons.   
Several factors point to a low epitope density as a likely explanation for the selective 
inability to respond to latently infected neurons. First, HSV-1 gB is a γ1 gene that is expressed at 
low levels prior to the initiation of viral DNA synthesis. Therefore, gB gene expression would be 
very low during the early stages of HSV-1 reactivation from latency in neurons. Moreover, 
neurons typically express very low levels of MHC class I, but appear to up-regulate expression 
during the HSV-1 lytic cycle (175,258). Indeed, we found that stressed CD8+ T cells were more 
impaired in cytokine production at low densities of epitope. Thus, it is likely that early in the 
reactivation process the density of gB498-505 epitope on neurons fails to reach the elevated 
threshold of stimulation required for cytokine synthesis and degranulation.  
It appears that the impaired response of CD8+ T cells to reactivating virus primarily 
reflects an intrinsic effect of stress on the functional program of the CD8+ T cells. Mixed cultures 
of stressed and nonstressed TG in which the origin of the CD8+ T cells could be determined by 
expression of different CD45 alleles showed less IFN-γ production by CD8+ T cells from 
stressed TG even when exposed to an identical stimulatory environment. These studies ruled out 
the possibility that stress-induced differences in antigen presentation or cytokine milieu 
accounted for the reduced IFN-γ production by CD8+ T cells in stressed TG. We also tested the 
effects of CD8-depleted stressed TG culture on nonstressed cells and found no difference in the 
production of IFN-γ. Moreover, the frequency of IFN-γ+ CD8+ T cells in nonstressed TG was 
similar when nonstressed TG were incubated alone or combined with stressed TG with or 
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without stressed CD8+ T cells, suggesting that the function of CD8+ T cells in nonstressed TG is 
not influenced by exposure to cells from stressed TG.  
Our studies demonstrate that the function of TG resident CD8+ T cells is very 
significantly compromised when mice are exposed to restraint stress. The combination of a 30% 
reduction in the number of HSV-specific CD8+ T cells and a 40% reduction in the frequency of 
CD8+ T cells capable of producing IFN-γ in response to reactivating neurons would translate into 
a 65% reduction in the capacity of CD8+ T cells to react to a reactivation event. This might 
represent an underestimation of the actual CD8+ T cell functional impairment since the IFN-γ 
response was measured after the CD8+ T cells were removed from the inhibitory 
microenvironment within the stressed animal. When we attempted to observe in vivo effects 
during the last stress session, we saw a significant decrease in the percentage of CD8+ T cells 
that synthesized IFN-γ in stressed mice, suggesting that our ex vivo culture analyses were most 
likely demonstrating an actual stress-induced effect, even in the absence of the inhibitory 
microenvironment.  However, as the numbers of cytokine-positive cells recovered in that assay 
were admittedly quite low, this conclusion is tentative. In addition to direct effects on the T cells, 
there may also be stress-induced effects on the ability of target cells to respond to cytokines. The 
synthetic glucocorticoid dexamethasone has been demonstrated to inhibit IL-2, IL-4, IL-7, IL-15, 
and IFN-γ signaling in part by disrupting expression of Jak-STAT pathway components 
(259,260). Glucocorticoids have also been shown to repress activation of the transcription factor 
NF-κB (261,262), as well as impair transcriptional activation by AP-1 (263). Whether signaling 
by these and other cytokines are disrupted in the latently infected TG, and in particular, within 
latently infected neurons, is the subject of current ongoing research in our lab.  
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5.2 DEFINING THE MECHANISMS OF RESTRAINT STRESS 
5.2.1 Glucocorticoids and the HPA axis 
The effects of stress on the TG-resident CD8+ memory T cell pool are profound. Since our stress 
protocol increases serum corticosterone levels, we tested whether direct corticosterone treatment 
could recapitulate stress-induced effects. In general, the effects of direct corticosterone treatment 
were similar to stress, except to a greater degree, except in regard to HSV-1 reactivation from 
latency. Where we saw a 30% reduction in CD8+ T cell number following stress, we observed an 
80-90% drop in number following corticosterone treatment. The loss in T cell numbers was due 
mostly to apoptosis, as nearly all the TG-resident CD8+ T cells costained with Annexin-V. 
Annexin-V is a molecule that binds phosphatidylserine when it is on the outer leaflet of the 
plasma membrane, an early event in apoptosis (241). In stressed mice, we observed a slight 
retention of activated cells, but following corticosterone treatment, the percentage of the 
population that expressed CD69 was significantly elevated. This result suggests that (i) activated 
cells are more resistant than non-activated cells to glucocorticoid-mediated apoptosis, (ii) 
glucocorticoids upregulate activation markers, or (iii) glucocorticoid-induced reactivation 
promotes viral gene expression resulting in increased epitope density on neurons, thereby 
activating the remaining cells. Although we cannot rule out the third hypothesis, we favor the 
first hypothesis in part because in vitro corticosterone treatment did not upregulate CD69 on 
splenocytes from naïve mice (data not shown) and in part because activated cells have been 
shown to be resistant to glucocorticoid-mediated cell death (264). In addition, CD69 is expressed 
equally by gB-specific and gB-nonspecific cells in the TG, and, like restraint stress, direct 
 113 
corticosterone treatment did not change the ratio of gB-specific to gB-nonspecific cells in the 
TG, even after 10 d of treatment.  
An interesting observation is that the number of CD8+ T cells in corticosterone treated 
TG remains approximately the same, regardless of length of treatment. What governs this 
phenomenon is currently unknown, but these data suggest two intriguing hypotheses. First, that 
approximately 10-20% of CD8+ T cells in the TG are resistant to the apoptotic effects of 
glucocorticoids. A second hypothesis is that the reduction is T cell number is a stochastic event, 
and the population of T cells is partially replenished throughout the 10 d of treatment, although 
the infiltration of cells to replace the dying cells would necessarily be enriched for gB-specific 
cells. We did not examine the expression of the intracellular glucocorticoid receptor (GR) in the 
context of these studies. Therefore, we do not know whether the cells that remain in the TG after 
4 d of treatment are inherently resistant to the receptor-mediated effects of glucocorticoids. 
Interestingly, if the cells remaining after 4 d of corticosterone treatment were intrinsically 
incapable of responding to glucocorticoids, we would expect them to homeostatically proliferate 
in order to fill up the empty space. Lymphopenia-induced proliferation is a newly-characterized 
phenomenon in which naïve cells expand to fill up space created by the radiation-induced death 
of lymphocytes (265,266). In the process, the naïve cells take on characteristics of memory cells 
and are even able to protect from bacterial challenge as effectively as true memory cells 
(267,268). Importantly, proliferation appears to be partly governed by cytokines such as IL-15, 
so perhaps the lack of proliferation we see is due to a dearth of proliferation-inducing cytokines 
due to the glucocorticoid treatment (265,269-271). However, it should be noted that in the 
presence of antigen (as in the latently infected TG) the requirements for IL-2 and IL-15 seem to 
be reduced (67,164). It will be important in future studies to examine whether the GR is 
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expressed in the surviving cells after corticosterone treatment, and whether progeny from those 
cells maintain its expression, or lack thereof.  
If the loss in T cell number is not due to differential GR expression, but is instead a 
stochastic process, then it would be expected that, with continuous glucocorticoid treatment, the 
numbers of cells in the TG would decrease over time, unless those cells are constantly 
replenished. Indeed, upon removing corticosterone, we observe a significant increase in 
proliferation throughout the mouse, including in the TG, spleen, bone marrow, and blood (data 
not shown). Thus, the proliferation potential is intact in the mouse, but the glucocorticoid 
treatment is preventing the increase in cell number, perhaps by killing cells as soon as they 
develop. Although we have not investigated the effects of glucocorticoid treatment in the 
thymus, it has been shown that thymocytes are highly susceptible to glucocorticoid-mediated 
effects (272,273). Moreover, glucocorticoids appear to be important for positive and negative 
selection (273-276). Thus, the direct corticosterone treatment may be inhibiting the 
replenishment of the T cell compartment by both killing the progeny of mature cells as well as 
by killing immature thymocytes before they can mature. It will be important in future studies to 
investigate whether the T cell repertoire following prolonged glucocorticoid treatment is 
impaired or limited in the cells that repopulate the mouse. The observation that T cell number in 
the TG remains constant between 4 and 10 d of treatment could indicate that there is a low level 
of cell trafficking into the TG at all times, but these newly emigrated cells are unable to fully 
recover T cell numbers until the glucocorticoids are removed from the system. This possibility is 
currently under investigation in our lab.  
Surprisingly, we never observed an increase in viral genome copy number following 
corticosterone treatment, even with the prolonged 10 d treatment. These results suggest that T 
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cell function is more important than T cell number in the TG, although this hypothesis has yet to 
be rigorously tested. We investigated CD8+ T cell ability to produce IFN-γ and degranulate. 
Under optimal stimulation conditions, we did not observe differences between the responses of 
cells from nontreated or corticosterone treated mice. Given that we did not observe functional 
compromise at optimal stimulatory doses in cells from stressed TG, it will be important to further 
examine the function capacity of corticosterone treated cells at suboptimal concentrations of 
HSV antigens. One major difference between the CD8+ T cell populations of stressed and 
corticosterone treated mice was the level of intracellular granzyme B. Restraint stress induced a 
significant increase in granzyme B retention per cell, but we did not observe a similar effect after 
corticosterone treatment. Importantly, when serum corticosterone levels were increased 
endogenously by daily handling and i.p. injections, as opposed to direct exogenous treatment in 
the drinking water, the intracellular granzyme B levels were not increased. Therefore, either 
source of glucocorticoids (endogenous vs. exogenous) shows a similar phenotype.  
5.2.2 Catecholamines and the SNS 
The other main effector arm of the stress response is the sympathetic nervous system (SNS). 
There are two fairly common ways to disrupt the SNS, both of which have been used in context 
of HSV-1 infections: 6-hydroxydopamine (6-OHDA) induced chemical sympathectomy, and 
nadolol, a β-adrenergic receptor antagonist (203,206,242). In our hands, i.p. 6-OHDA treatment 
resulted in the death of all mice we treated, some as quickly as 2 d after initial treatment, in both 
HSV-1 infected and naïve mice (data not shown). However, treatment of mice with nadolol 
during stress was able to reduce the stress-induced granzyme B increase in two out of 3 
experiments. Therefore, the potential exists that the increase in intracellular granzyme B, which 
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could be an indicator for reduced lytic granule release, is a catecholamine-mediated effect. Given 
that nadolol treatment has been shown previously to restore cytotoxic function to compromised 
HSV-specific effector cells (203,206), our results indicate a model of restraint stress-induced 
catecholamine release that can impair the CD8+ T cell ability to degranulate, separate from the 
glucocorticoid-mediated loss of T cell number.  
Perhaps the most intriguing observation is that direct glucocorticoid treatment does not 
induce reactivation of latent HSV-1, but depletion of T cells or restraint stress (which also 
compromises lytic granule release) does result in elevated genome copies. The obvious 
hypothesis is that degranulation is an important effector component of the CD8+ memory T cells 
in controlling latent infections in vivo. Mice deficient in granzyme B survive initial HSV-1 
infection (data not shown), but it is currently unknown whether these mice have deficiencies in 
maintaining latent virus or are more susceptible to reactivation than wild-type. Granzyme A, 
another lytic granule component with known non-cytolytic functions (277), has been shown to be 
important in restricting the spread of HSV-1 throughout the peripheral nervous system (278). We 
did not investigate granzyme A in our models of stress or direct corticosterone treatment. 
Moreover, mice deficient in perforin survive infection and control viral titers in the cornea as 
well as wild-type mice, suggesting that, in our model, the effects of granzyme B in control of 
latent virus may be mediated in vivo by a perforin-independent, noncytolytic mechanism (279).  
The relative roles of lytic granules and cytokines in CD8+ T cell-mediated control of 
latent HSV-1 infections are still under investigation. The studies presented here suggest that each 
mechanism may be important in vivo for proper maintenance of viral latency. We also present a 
model in which there is a minimum threshold required for T cell protection. In our hands, T cell 
function correlates with protection better than T cell number correlates with protection, at least 
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as far as degranulation is concerned. It should be noted, however, that we did not examine the 
potential caveat that in vivo corticosterone treatment may itself limit reactivation of latent virus, 
thereby bypassing the requirement for T cell-mediated protection. Indeed, a previous study has 
observed that treatment of mice with the synthetic glucocorticoid dexamethasone did not alone 
induce reactivation and dexamethasone treatment actually reduced the frequency of  
hyperthermic stress-induced reactivation (251). On the other hand, in vitro treatment of T cell 
depleted TG culture with 10-6 M corticosterone neither inhibited nor enhanced HSV-1 
reactivation from latency, suggesting corticosterone most likely affects T cells more than 
neurons, although, we did not address the numbers or function of the surviving T cells in these 
cultures following corticosterone treatment. Moreover, when exogenous virus-specific CD8+ T 
cells were added to the cultures, we observed nearly full protection from reactivation, suggesting 
corticosterone may affect T cell number but not function. Therefore, while our data does not 
indicate a reactivation-suppressing role of corticosterone, the possibility that direct 
corticosterone treatment inhibits HSV-1 reactivation has not been formally ruled out. Future 
studies are required to examine the ability of stress-induced catecholamines to compromise T 
cell cytotoxic and noncytotoxic effector functions mediated by release of lytic granules and the 
relative roles these mechanisms, along with T cell number, synthesis of IFN-γ, and production of 
other cytokines, to protect the host from HSV-1 reactivation from latency.  
5.3 DISRUPTION OF IMMUNITY DURING PRIMARY INFECTION 
Psychological stress during latent infection induces reactivation of latent virus in part by 
compromising the CD8+ T cell efficacy. How would a similar compromise early in infection, 
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while T cell memory is still in development, affect the establishment, function, and susceptibility 
of the memory pool to stress?  
We addressed this question by stressing mice from 4-8 d p.i., during the priming and 
initial expansion phase of the T cell effector response. We observed a 56% reduction of gB-
specific CD8+ T cells in the TG at 8 d, suggesting either the expansion of cells was reduced or 
infiltration into the TG was delayed or inhibited. Reductions in cell number were also seen for 
the overall CD8+ T cell pool and CD4+ T cells. These reductions corresponded with an inhibition 
of clearance of live virus from the cornea. Initial clearance of virus from the eye is dependent 
mostly on innate immune mechanisms, not the adaptive T cell response (68-71). We did not 
investigate whether our model of restraint stress affected the innate immune response, although 
there is plenty of evidence in other models for stress-mediated innate immune suppression 
(179,216,223,280). Restraint stress did not result in increased viral genome copies in the TG at 8 
d p.i.; direct corticosterone treatment 4-8 d p.i., which resulted in a greater loss of T cell number 
in the TG than stress, led to a significant increase in viral genome copies in the TG. Perhaps the 
minimum number of innate and adaptive effector cells required to drive HSV-1 into latency was 
not met when mice were treated with corticosterone.  
Interestingly, during the contraction phase (14 d p.i.), the numbers of T cells in the TG 
had equilibriated to wild-type levels in mice that had been stressed 4-8 d p.i. Given that there is a 
54% reduction in gB-specific IL-7Rα+ T cells in the TG at 8 d, the equilibriation to wild-type 
numbers at 14 d could indicate a restoration of infiltration into the TG. Future studies will 
address this possibility. Surprisingly, although we observed an overall reduction of CD8+ T cells 
in the TG after stress early, without selectivity toward virus-specificity, the numbers of gB-
nonspecific IL-7Rα+ memory precursor cells was not reduced following stress. In fact, numbers 
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of gB-nonspecific IL-7Rα+ cells did not even change between 8 and 14 d p.i. These data suggest 
that any infiltration of IL-7Rα+ cells into the TG in the intervening period was nearly entirely a 
component of the gB-specific population. Alternatively, proliferation of IL-7Rα+ cells between 8 
and 14 d p.i. might only occur within the gB-specific population. The significance of these 
observations is still unknown.  
Similar numbers of IL-7Rα+ cells at 14 d led to similar numbers of CD8+ T cells in the 
TG at 34 d p.i. Thus, stress early in infection does not affect the establishment of a CD8+ 
memory T cell pool in the TG. Similar results have previously been observed in secondary 
lymphoid organs (221,223). However, in these previous studies and elsewhere, the functionality 
of the memory T cells was impaired as measured by cytokine production and cytotoxicity. 
Interestingly, we observed a significant decrease in the number of CD4+ T cells following stress. 
CD4+ T cells have been shown to be important during the generation of CD8+ T cell effector 
responses to produce and maintain fully functional memory cells that can protect the host from 
pathogen rechallenge (281-284). Whether the stress-induced reduction of CD4+ T cells (or a 
compromise in their functionality) during the initiation of the immune response has an effect on 
the generation, maintenance, or functionality of the CD8+ memory T cell response is currently 
unknown but is an issue of considerable interest. Moreover, the ability of APC to present 
antigens and prime CD8+ T cells may be impaired when mice are stressed 4-8 d p.i. 
Corticosterone has been shown to interfere with MHC antigen processing and presentation in 
dendritic cells (192). APC that are hindered in their presentation of antigen to T cells by stress 
could potentially induce compromised CD8+ effector and memory responses. Admittedly, we 
have yet to fully characterize TG-resident CD8+ memory T cell responsiveness to ex vivo 
stimulation with antigen, however, our initial results reveal the potential for subtle differences in 
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the efficacy of the memory population generated under stressful conditions. Indeed, optimal 
stimulation provides few differences between treatment groups whenever test, so to more 
efficiently measure the memory population after early stress, we will have to stimulate the cells 
under suboptimal antigen concentrations or examine their responsiveness to reactivating virus. 
These experiments will be very useful at determining the longterm effects of stress during the 
generation of a memory response. Stress may even prove to be a major component in explaining 
the variety in HSV-1 reactivation rates in people. As is shown here, psychological stress can lead 
to reactivation by disrupting T cell immunity at the site of latency. If the memory cells were 
already deficient due to stressful events early in the life of the host, then reactivation might be 
more facilitated and occur more often.  
For the memory response that develops after stress early to be more susceptible to stress 
during latency, there would have to be some measurable difference between the cells that are 
generated after early stress and those that arise without stress. Some potential differences could 
be in expression of glucocorticoid or β-adrenergic receptors. Without knowing the exact 
differences between memory cells that develop after early stress versus wild-type, nonstressed 
memory cells, we chose to measure the susceptibility of each memory pool to stress during 
latency. Although not significant, there was a definite trend toward greater reduction in TG-
resident CD8+ T cell number 34 d p.i. after stress both early and late in infection (4-8 and 30-34 
d p.i.) than either single stress treatment alone. Indeed, mice stressed during latency had fewer 
cells in the TG than nonstressed mice or mice stressed early, and mice stressed both early and 
late had an approximately 35% reduction from mice stressed late alone. Additonally, it appears 
that stress early may sensitize the memory pool to respond with a greater functional impairment 
to subsequent stressors, as we observe a slight increase in viral genome copies in mice stressed in 
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both sessions. It should be noted that we did not observe a significant difference in HSV-1 
genome copy number when mice were stressed during latency until 38 d p.i., a few days after the 
cessation of stress. Therefore, it will be important to assess the viral genome copy number at 38 
d, instead of 34 d presented here, to make the most accurate assessment of whether multiple 
stress treatments leads to greater reactivation than single stress treatments. Further investigation 
into the cumulative effects of multiple stress treatments may reveal fundamental properties of 
memory T cell maintenance in humans, as well as correlate the perception of stress in humans 
with susceptibility to HSV-1 reactivation from latency and pathogenesis of other diseases. 
5.4 CONCLUDING REMARKS 
Viewed in the context of these findings, the “spontaneous” HSV-1 reactivation observed in 
humans but not in mice might reflect periodic exposure of humans to a more stressful 
environment. Moreover, human neurons might express a lower density of HSV-1 epitopes than 
mouse neurons during HSV-1 reactivation from latency due to the selective capacity of the HSV-
1 immediate early protein ICP47 to block human TAP transport of viral peptides for loading on 
MHC class I for presentation to CD8+ T cells (177,285). In conjunction with a stress-induced 
elevation in the threshold of epitope density required to activate CD8+ T cells this would render 
humans more susceptible to HSV-1 reactivation than mice.  
Our findings provide a broader conceptual framework in which to consider HSV-1 
latency and reactivation. The fact that latency appears to be uniquely established in neurons 
underscores the importance of the neuronal microenvironment in the establishment and 
maintenance of the latent state. However, a growing body of data including this report supports 
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the notion that maintenance of latency in some latently infected neurons requires ancillary 
support from contiguous CD8+ T cells. Moreover, our findings provide a link between stress, a 
known inducer of HSV-1 reactivation, and transient functional compromise of TG-resident CD8+ 
T cells. We propose that the incidence of recurrent herpetic disease might be reduced by 
strategies that augment the numbers or function of HSV-specific CD8+ T cells within the latently 
infected sensory ganglia, or by reducing the effects of stress on the function of these cells.  
 
 
 123 
6.0  SUMMARY 
The studies presented in this thesis address fundamental questions about the role of the adaptive 
immune response in the control of latent HSV-1 infections. Here we show for the first time that 
CD8+ T cells are required during latency to inhibit the replication of viral genome, even in the 
absence of an overt reactivation stimulus. The association of stress with HSV-1 reactivation has 
long been proposed in humans, but no previous studies have adequately addressed potential 
mechanisms that involve the immune response at the site of latency, in animal models or in 
humans. Here we show, for the first time, that a psychological stressor can compromise the 
function and numbers of T cells in the ganglion during latency, and, that stress-induced 
disruptions of T cell efficacy are associated with reactivation of latent virus.  
Additionally, we put forth a mechanism by which psychological stress can differentially 
regulate T cells by the two main arms of the stress response: the HPA axis and the sympathetic 
nervous system. Here, glucocorticoids mediate the survival of the T cells and catecholamines 
influence the effector functions of the T cells. Interestingly, in our model, it appears that the 
number of functional CD8+ T cells is less important in inhibiting reactivation in vivo than the 
functional capacity of those cells. Whether the intensity of the stress changes the ratio of 
glucocorticoid to catecholamine release is unknown, but a model in which moderate stressors 
only mediate some effects while more intense chronic stressors can dyregulate the T cell 
response more thoroughly is intriguing.  
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The effects of stress during the primary infection are also important. Although it had been 
shown previously that stress prior to HSV-1 infection resulted in a general impairment of the 
memory T cell response, the direct effects on cells within the ganglion had never before been 
investigated. Whether the resulting TG-resident memory cells are impaired in their ability to 
control reactivation or respond to a induced reactivation event was not fully tested in these 
studies, however, the potential exists that the memory response could be compromised, and thus, 
individuals who underwent stressful experiences when they were first infected with HSV-1 
might be more susceptible to the T cell compromising effects of stress many years later. An 
enhanced sensitivity to stress could explain why some people experience reactivation events 
much more often than others.  
 By understanding how stress influences the HSV-specific immune response we 
can ultimately design strategies for alleviating reactivation-inducing effects of stress, thereby 
reducing recurrent disease. Importantly, the data presented here suggest that memory cell 
effector functions are more important in preventing reactivation than the numbers of cells 
responding. Therefore, therapeutic vaccine strategies meant to only enhance memory cell 
number may be short-sighted in their goals; a better strategy may be to improve the effector 
functions of the cells that are already there.  
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